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Abstract 
 
 
In the present work analysis of exhaled breath has been proposed as a novel way to 
detect disease, to monitor disease progression, and to monitor clinical intervention. 
An analytical method of analysis based upon two stages thermal desorption capillary 
gas chromatography and mass spectrometry was developed for the analysis of breath 
samples. All the steps of the analytical procedure were evaluated, trying to identify 
the critical aspects in order to optimize the entire procedure. A novel breath collection 
media has been developed that is cheap, disposable and readily available. This 
material allows breath samples to be collected in a novel manner. After validation the 
procedure was applied to real samples and preliminary experiments were performed 
aimed at estimating the variability of the composition of breath as a function of time 
of day and the inter-subject variability. In particular the trend in time of the two 
principal compounds in breath, acetone and isoprene was observed. The data showed 
a wide inter-variability between different people and also confirmed that a meal can 
influence breath composition. For this reason if possible, it was better to collect a 
breath sample in the morning before eating. Single substances or sets and patterns of 
exhaled markers were also investigated in order to establish correlations between the 
chemical composition of breath and patients’ clinical conditions. 
Preliminary studies were performed on patients with end-stage renal disease. The 
results underlined the capacity of the analytical procedure to appreciate small 
variation in breath composition. In particularly in people under dialysis treatment two 
compounds were found to show significant differences in breath concentration 
between patients and healthy people before the dialysis and no important differences 
after. These two compounds should become an additional and important parameter to 
determine the end of the dialysis treatment. 
In parallel a breath collection system prototype has been designed that enables 
samples of dead space air to be separated from end tidal breath and be collected 
independently. This device is also novel and has a great potential in breath analysis 
field. 
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CHAPTER 1 
 
 
State of the Art 
 
 
 
 
1.1   Introduction 
How many times do we hear expressions such as: “To sigh with relief, to breathe 
deeply, to take a breath of fresh air, to feel choked, to take your breath away“. These 
are all phrases refer to our moods. We often feel tired, lazy, dulled or very commonly 
we feel stressed. When an emotion is exaggerated respect to an external stimulus, it 
means that there is not sufficient oxygen in the body and in the mind. Oxygen enables 
the mind to work and if there is a lack of oxygen, the blood has to flow faster. 
Meanwhile we lose clarity of thought and our mood changes for the worse. Everybody 
knows just how important breathing is, but in reality how much do we know about the 
respiration process? When we breathe many organs are involved, in fact the inspired air 
passes through the airways to reach the lungs, which represent the real respiration 
organ1. When we breathe, we bring oxygen into the body and the produced substances 
are eliminated. Besides containing principal gases (nitrogen, oxygen, carbon dioxide, 
inert gases) and 98% of water, human breath consists of a great variety of organic 
compounds present at very low concentrations. What is eliminated may come from 
products of our metabolism or from substances that we have inhaled and adsorbed from 
an external environment. Breathing is at the base of the life and enables our organism to 
carry out the principal vital function. Therefore, chemical composition of exhaled air 
reflects the general metabolic conditions and it may give useful and precious 
information on the state of health of a person. For these reasons breath has the potential 
to become a key for reading our organism. 
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1.2   State of the art 
 
Breath scientific research started in 1784, when Antoine Laurent Lavoisier, father of 
modern chemistry, and Pierre Simon Laplace, analyzed the breath of a guinea pig and 
observed that the animal burned oxygen and produced carbon dioxide. This discovery 
was the first proof of food combustion in human body2, 3. 
 
In the mid 19th century, colorimetric tests were developed that led to the detection of 
volatile organic compounds (VOCs) in breath at low concentrations. One of the first 
colorimetric analyses was developed by the German Nebelthau. He observed a rapid 
and intense colour variation in an alkaline iodine solution, bubbling in the breath of 
diabetics. The colour variation was induced by the presence of a high amount of 
acetone in breath3, 4. 
 
In 1874 the British scientist Francis Anstie used a colorimetric method to highlight the 
presence of ethanol in breath. By bubbling breath through an acid chromic solution he 
observed a colour variation from red to green due to the presence of ethanol. With other 
experiments the scientist demonstrated that the amount of ethanol eliminated from 
breath was less than the ethanol ingested. He deduced that most of the ethanol was 
metabolized3. 
 
It was only in 1971 that Linus Pauling carried out the first systematic breath 
characterization, condensing volatile compounds in a cold trap (made from a stainless 
steel tube cooled with dry ice). An analysis of the condensate using gaschromatography 
and mass spectrometry highlighted that human breath samples are very complicated as 
they contain thousand of different compounds3.  
 
The most significant results on the studies of the correlation between metabolism and 
the presence of organic substances in human breath, and between pathologies and 
markers are reported below. However, in most cases the metabolic pathways that lead 
to their formation are not well known yet5, 6, 7. 
 
In the breath of patients with hepatic cirrhosis, sulfur compounds such as 
ethylmercaptan, dimethylsulphide and dimethyldisulphide were identified. These 
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compounds were produced in the human organism from an incomplete metabolism of 
methionine, intermediate of the transaminase process2, 6, 8, 9, 10. 
 
In the breath of patients suffering from lung cancer, alkanes with low molecular 
weights, such as hexane, heptane, pentane, methylpentane and benzene derivatives 
were identified. They are produced from an alteration in the lipid peroxidation process 
(oxidative stress), probably due to an increase in oxygen free radical activities in the 
cancer cells. Active species of oxygen are continuously produced in the mitochondrion 
and exit in the cytoplasm where they cause peroxidative alterations in proteins, 
polyunsaturated fatty acids and in DNA. Oxygen free radicals degrade the cell 
membranes and convert polyunsaturated fatty acids into volatile alkanes, which are 
eliminated in breath. These alkanes could be converted into alkyl alcohol by 
cytochrome P450 (CYP) mixed with oxidase enzymes, which are active in lung cancer. 
The activation of CYP enzymes in patients affected by lung cancer can accelerate the 
degradation of alkanes and methylalkanes produced by oxidative stress4, 7, 11, 12, 13, 14. 
 
Increases in 8-isoprostane, hydrogen peroxide and 3-nitrotyrosine concentration have 
been found in the breath condensate of people suffering from lung inflammation 15.  
 
In patients undergoing dialysis a decrease of some compounds in blood was 
highlighted. Some of these include nitrogenous compounds such as urea, ammonia, 
methylamine, ethylamine, dimethylamine and trimethylamine16, other are aromatics 
compounds such as m–cresol and other uremic toxins such as malondialdehyde or 
oxalic acid16. In the literature there are few papers on breath variation after dialysis 
treatment and only some studies concerning pentane17 and ammonia2, 6, 18. 
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1.3   Tests used in the clinical diagnosis 
 
Many tests on breath analysis have been approved by the U.S. Food and Drug 
Administration (FDA) and are now used for the diagnosis and monitoring of some 
diseases: 
 
• A nitric oxide breath test is used for monitoring asthma therapy. During tidal 
respiration, the nitric oxide levels in asthmatic people can reach higher values 
than in healthy people. It has been demonstrated that the breath concentration of 
nitric oxide is proportional to the degree of eosinophilic inflammation of the 
airways and decreases if the subject starts a corticosteroid therapy19. It is known 
that nitric oxide forms almost exclusively in the superior and inferior tract of the 
airways and diffuses towards the lumen. The alveolar level of nitric oxide is 
very low due to the fact that it easily linked with hemoglobin in capillary blood. 
In the inflamed airways of asthmatic people the production of nitric oxide is 
higher than in healthy people20.  
 
Other tests (listed below) determine the concentration of a volatile substance directly 
taken (ethanol test) or derived from the metabolism of a specific precursor, given to the 
patient some hours before the test. 
  
• The ethanol screening test is used to determine alcohol levels in blood. The 
subject has to breathe inside a plastic tube; 1 cm3 of breath is collected through 
a piston. The sample is sent inside a combustible cell where an electron current 
is generated. The electric current measured is proportional to the alcohol 
concentration in blood21, 22.   
 
• The hydrogen breath test is used to diagnose intestinal diseases, such as 
malabsorption syndrome3 or pancreas diseases. Usually this test is used with 
children with cystic fibrosis. A quantity of rice starch is given to the child; 
children with cystic fibrosis are not able to secrete a sufficient amount of 
amylase enzyme to digest the flour in the small intestine. The bacterial present 
in the intestine are the final part of the digestion process and produce high 
amounts of hydrogen. The hydrogen is eliminated by the breath, thus we can 
observe a significantly increase in the hydrogen breath content3, 23. 
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• The 14CO2 breath test is used to diagnose other pancreas diseases. A quantity of 
14C labeled triglycerides is given to the patient; the triglycerides are metabolized 
from pancreas enzymes, producing a certain amount of labeled 14CO2. If the 
amount of 14CO2 is lower than a specific value, it means that the pancreas 
functionality is reduced3, 23. 
 
• The infection caused by Helicobacter pylori is diagnosed by an urea breath test. 
Helicobacter have the urease enzyme, which is not present in human organism. 
It enables to urea to be metabolized thus producing CO2. If a quantity of labeled 
14C urea is given to the infected subject, the bacteria metabolizes it in the 
stomach, producing 14CO2. This gas is eliminated by breath, thus a breath 
analysis is performed at a certain time after the administration, revealing the 
infection3, 23. 
 
In addition to these tests, many studies on breath, analysis and the characterization of 
healthy people and subjects suffering from different pathologies have been reported in 
the literature. However, going from what is reported in the literature to real clinical 
practice is not straightforward, since the correlation between breath composition and a 
subject's state of the health is difficult to understand24,  25. 
In terms of the medical application of breath analysis, the differences between the 
chemical breath composition of healthy people and people with diseases are not great. 
Only in a few cases were found compounds in the samples of people with a disease and 
not in healthy people. Usually small differences in compound concentrations are 
observed, thus very accurate analytical techniques are needed. 
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1.4   Exposure assessment 
 
In human breath there are thousands of VOCs. These compounds can be generated 
inside the body (endogenous substances) or can be adsorbed from exposure to the 
environment (exogenous substances). In fact breath VOCs content can show whether a 
subject has been exposed to a polluting environment26, 27. The VOCs used in productive 
activities and industrial processes (laundry, the shoe industry, the production of paints 
or inks, etc.), can be adsorbed from the skin or through inhalation and are eliminated 
with breath28, 29, 30, 31.  Most of these compounds are toxic and can cause several 
diseases, such as cancer (benzene and toluene) or pulmonary inflammation (acrolein 
and an α,β unsaturated aldehydes). In most cases it is very difficult to find a correlation 
between the chemical agents and the disease, due to the complexity of interactions 
between human organisms and the environment, particularly when a lot of time has 
passed between exposure and the onset of the disease32. 
 
For some solvents biological monitoring involves sampling and the analysis of blood or 
urine. These are invasive methods, there are operative difficulties during sampling and 
it is possible to perform only a limited number of analyses. For this reason, breath 
analysis has been proposed as an alternative. Inhaled air during exposure stays inside 
the alveoli for sufficient time to permit to the VOCs to reach equilibrium with the blood 
of the pulmonary arteries. This equilibrium is regulated by partition coefficients, which 
determine the relative blood/breath concentration of each compound33. Thus the 
analysis of solvents in expired air may be an indication of their levels in blood28. Breath 
measurements principally reflect recent exposures. This is due to the fact that after a 
subject has stayed in a place for a few hours, equilibrium is reached with the ambient 
air; at this point breath principally reflects the actual exposure of the subject34. 
 
Breath analysis is also used to determine occupational exposure to industrial solvents 
and many studies have demonstrated the correlation between expired VOCs and 
chemical substances in work places32. Guidotti et al.35 assessed the amount of 
chlorinated solvents in the breath of exposed subjects in the work place. Chloroform, 
trichloroethylene, tetrachloroethylene, tetrachloroethane and carbon tetrachloride were 
assessed. Detection limits of 0.5 and 5 ppb were found useful to analyze these 
compounds in the breath of subjects exposed to very low concentration levels.  
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Chen et al.36 evaluated the correlation between the exposure of normal people to 
toluene, xylenes and ethylbenzene and the concentrations in the breath of petrol station 
attendants. Attendants provided breath samples after their shift at the petrol station and 
ambient air samples were simultaneously collected. It was found that the levels of 
toluene and xylenes correlated with those of ambient air, whereas the ethylbenzene 
levels were too low to show a correlation with the exposure that a particular subject 
experienced. The concentrations of toluene, xylenes and ethylbenzene in breath were in 
the ranges 16 to 200, 5 to 66, 1 to 33 ng/l respectively. 
 
Sweet et al.37 developed a method to determine perchloroethylene in breath. The 
measurements taken from exposed subjects gave values ranging from 7 to 44 μg/l, with 
variability coefficient of about 6 %.  
 
Perbellini e al.38 demonstrated the correlation between the concentrations of 1,3-
butadiene, 2,5-dimethylfurane and benzene in breath, together with urine and blood 
samples taken at the same time. The median concentrations of 1,3-butadiene, 2,5-
dimetilfurano and benzene in breath were     1 ng/l, 0.5 ng/l, and  6 ng/l, respectively. 
 
The American Conference of Governmental Industrial Hygienists (ACGIH)39 proposed 
indexes of biological exposure in breath for some compounds, which represent the 
probable concentration values for healthy workers exposed to these compounds in the 
air at a concentration equal to the TLV (Threshold Limit Value). 
 
The biological exposure indexes for some compounds, as defined according to ACGIH, 
are reported as follows: 
• Tetrachloroethylene is the solvent used in dry washing. Within the industry it is 
also used to skim the fat from metals and in the preparation of glues and 
adhesives. It is measured before the last shift of the working week and has a 
limit of 5 ppm. 
 
• Ethylbenzene is an intermediate product in styrene production. It is used to 
obtain resins and synthetic rubbers, or as a solvent for paint or motor cleaning. 
It is measured at the end of the working week. 
 
 8
• Methylchloroform is used for degreasing and cleaning. It has fallen into disuse 
due to the damaged ozone. It is measured before the end of the daily shift; the 
TLV is 40 ppm.  
 
• Trichloroethylene was banned in 1977 in the USA; it was used as an anesthetic 
and as a solvent for corn sterilization. Now it is used for metal degreasing, as a 
painting solvent and for dry washing. 
 
Breath analysis is a potential biomarker for occupational and environmental exposure 
since its major advantage is that it involves a noninvasive procedure. However, more 
research is necessary for it to be used routinely. It is especially important to establish 
relationships between exposures (dose) and level of substances in the various breath 
samples32. 
 
 
 
 
1.5   Physiology of respiration 
The major function of the respiratory system is the gas exchange between the external 
environment and an organism's circulatory system. In humans, this exchange facilitates 
the oxygenation of the blood with a concomitant removal of carbon dioxide and other 
gaseous metabolic wastes from the circulation.40 The simultaneous activity of the 
respiratory apparatus and the cardio-circulatory system guarantees that oxygen is 
brought to the tissues and that carbon dioxide is removed. Oxygen has to reach every 
cell, to be used for metabolic oxidation and the production of energy, while carbon 
dioxide, which is an end-product of cell metabolism, has to be removed from venous 
blood and transferred to the lung to be eliminated41. 
The respiratory system can be divided in two sections (Figure 1.1): dead space which 
mainly acts as a conducting airway (nose, pharynx, larynx, and other airways without 
alveoli), and a section whose main function is gas exchange (alveoli and alveolar 
sacs)42. 
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Figure 1.1 Respiratory system 
 
Upon inhalation, a gas exchange occurs in the alveoli, the tiny sacs which are the basic 
functional component of the lungs. The alveolar walls are extremely thin (approx. 0.2 
micrometers). These walls consist of single layers of epithelial cells in close proximity 
to the pulmonary capillaries which consist of single layers of endothelial cells. The 
close proximity of these two cell types allows permeability to gases and, hence, a gas 
exchange.  
The blood supplying the alveoli is pumped to the lung from the right ventricle of the 
heart and then flows into the entire body. Thus it is poor in oxygen (used from the cells) 
and rich in carbon dioxide (produced from cells). (Figure 1.2)  
 
Figure 1.2  Gas exchange in the alveoli 
The chemical process of gas exchange is diffusion: a substance always diffuses from A 
to B if the concentration or pressure is higher in A rather in B. Thus in the alveoli the 
oxygen pressure (100-110 mmHg) is lower than in the inspired air and higher than in 
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blood capillaries (40 mmHg). Carbon dioxide pressure in the alveoli, on the other hand, 
is lower (40 mmHg) than in capillary blood (46 mmHg) and the CO2 moves in the 
opposite direction of the O2. For the CO2 the difference in pressure is small, but it is 
enough to eliminate the carbon dioxide produced by the organism as a result a good 
diffusivity of this gas. It is also important to consider that gas exchanges are also 
regulated by gas solubility in the liquid solution43. 
A typical respiratory cycle in a time span of about 5 seconds involves the exchange of 
half a litre of air with the lungs (tidal volume), so that the total ventilation, i.e. the 
volume of air moved in and out of the lungs per unit of time, is about 6 l/min. Not all 
the air we breathe is useful for the renewal of respiratory gases. 
 
Before inspiration, dead space is filled with end-tidal air remaining from the previous 
respiratory cycle. End-tidal air is the last fraction of expired air, whose composition 
resembles alveolar air. During inspiration, half a litre of fresh ambient air is then 
inhaled into the body, but only the first 350 ml reach the alveoli together with 150 ml of 
end-tidal air contained in the dead space, where they are diluted and mixed with 
alveolar air. During expiration, 150 ml of ambient air, which filled the dead space, and 
350 ml of air coming from the alveolar region are exhaled through the nose and/or 
mouth in sequence. By analyzing a respiration cycle, it can be seen that dead space is 
alternately filled with ambient and end-tidal air, and that only 350 ml of ambient air 
actually ventilates the lungs. Since the volume of air contained in the lungs during 
normal breathing is approximately 3 l, it follows that the composition of alveolar air is 
pretty stable during respiration (the cyclic variations of oxygen and carbon dioxide are 
about 2% and 5%, respectively). 
 
During expiration the breath composition changes in order to empty the airways and the 
lungs. Such a process can be followed by measuring the CO2 in breath, see           
Figure 1.36,55. 
Three phases can be identified: during Phase I the air in dead space is eliminated and 
the composition of this fraction is low in CO2, being similar to inspired air; during 
Phase II the partial pressure of CO2 increases quickly until it reaches a maximum value 
of 35 mmHg; only in Phase III is the alveolar air eliminated, containing the volatile 
compounds released from blood.  
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Figure 1.3 CO2 breath profile during the respiration process  
 
Ambient air is the main source of xenobiotic contaminants and oxygen. Its content of 
oxygen and carbon dioxide is fairly constant, while the concentrations of xenobiotics 
may be highly variable. 
Dead space air has a composition close to ambient air (but a higher water content). 
Differences may arise due to the chemicals originating and/or released in the 
conducting airways or to gas exchanges with the mucus layer (mainly for water soluble 
compounds). 
 
The composition of alveolar air is due to the interaction of ambient air with blood 
through the alveolar membrane. There are considerable non-homogeneities in the 
composition of alveolar air in different lung regions even in healthy subjects, since 
posture and gravity alter both local ventilation (exchange of the air in the lungs) and 
perfusion (blood circulation). Pulmonary ventilation and perfusion are mainly regulated 
by respiratory and cardiac frequency44,55.  
When the composition of ambient air changes, the time needed for each breath fraction 
to reach a new equilibrium ranges from a few seconds for dead space air to minutes or 
hours for alveolar air. 
In most cases, blood is the main source of markers and for this reason alveolar air 
should be considered the most representative of an individual’s condition. If markers 
are released from conducting airways, dead space air should be sampled. 
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Dead space and end-tidal air can be distinguished on the basis of their composition. 
Unfortunately, a net separation cannot be made between the two due to the absence of a 
sharp anatomical boundary. A boundary region has been identified at the terminal 
bronchioles with a 2 mm diameter, where the convective flow gives way to diffusion43. 
The diffusion and mixing of gases in this region depend on their physical–chemical 
properties, on the rate of respiration and on the anatomy. The concentration of 
expiratory gases is also greatly influenced by the ratio of ventilation-to-volume, 
perfusion-to-volume and ventilation-to-perfusion inequalities45, as well as lung 
volume46, posture47 and flow rate48. 
Thanks to the presence of different path lengths of dead space between the mouth and 
alveoli, the lack of a uniform velocity across the cross section of the tracheobronchial 
tree, and due to convective and diffusive mixing of gases at the boundary region, the 
transition in expired air is not so sharp, so that the concentration profile is rather          
S-shaped. (Figure 1.4) 
 
In 1948 Fowler defined dead space as the volume of the conducting airway until the 
point where a large change in gas composition occurs, and he proposed a method for 
determining its value49. 
 
 
Figure 1.4  CO2 concentration profile as a function of expired volume Fowler’s 
graphic method is also shown: dead volume corresponds to the point where (a) and (b) 
regions have the same area.  
 
This consisted of giving the subject a single breath of pure oxygen and monitoring the 
nitrogen concentration in the exhaled air. The nitrogen concentration profile in exhaled 
air resembles the carbon dioxide profile reported in Figure 1.4. The volumes i.e., 
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shaded areas a and b are equivalent and represent the ideal transition point between 
dead space and alveolar air. Fowler used nitrogen as a tracer gas as he was able to use a 
fast sensor to measure its concentration levels in the expired air. In cases where the 
diffusivities were comparable, other gases, such as oxygen, carbon dioxide or helium, 
provided similar results50, 51.  
 
Bohr using carbon dioxide as a tracer gas proposed a different method based on mass 
balance at the end of the 19th century52. His formula was the expression of a simplified 
model that considered the expired breath as the sum of two unmixed homogeneous 
fractions, the inspired air contained in the dead space and the alveolar air from the 
lungs: 
 
     VE × CE = (VE – VDS) CA + VDS × CDS                        (1) 
 
Where VE and VDS are the volumes of expired and dead space air, CE is the average 
concentration of carbon dioxide in expired air (the value that would be measured in a 
sampling bag), and CDS and CA are the concentrations of the same gas in dead space 
and alveolar air respectively. The contribution VDS · CDS of dead space air to the carbon 
dioxide balance can be neglected as the concentration of this gas in ambient air is close 
to zero. If the carbon dioxide concentration CA in the alveolar air is known (it is 
reasonably close to the end-tidal CO2 concentration level), Bohr’s formula can be 
rearranged and used to estimate either the dilution factor D of the alveolar air due to 
dead space air: 
 
                                       E E A
A E DS E
V V CD
V V V C
= = =−                       (2)  
 
or the dead space volume: 
 
                                        (1 )EDS E
A
CV V
C
= −                                              (3)  
 
Even though they provide about the same estimate of dead space volume in healthy 
individuals, there is an important conceptual difference between Bohr’s and Fowler’s 
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approaches, originating from the use of tracer gases such as carbon dioxide and 
nitrogen which are involved or not involved in the respiration process. Fowler’s method 
estimates the volume of the conducting airways to the point where the pure oxygen 
delivered to the subject mixes with the nitrogen in alveolar air (anatomic dead space). 
Bohr’s method on the other hand, measures the volume of air not involved in the gas 
exchange with blood (physiological dead space). 
 
The difference is due to the alveolar dead space, i.e. the volumes of the lung constituted 
by alveoli that are ventilated but insufficiently perfused (or perfused but poorly 
ventilated) for a gas exchange to be effective. Such volumes are normally very small 
(less than 5 ml) in healthy individuals, but can increase dramatically in patients affected 
by lung diseases characterized by ventilation or perfusion impairments such as 
bronchitis, emphysema or pulmonary embolism. Thus, if Bohr’s method is important to 
clinicians in order to assess the alveolar dead space, at the same time the estimate of the 
dilution factor may be used by researchers in breath analysis to normalize data and 
increase reproducibility42. 
 
 
 
 
1.6   Breath sampling techniques 
 
Despite its great potential, breath analysis is still far from being used in clinical 
practice. A list of argued reasons has been proposed by Risby et al53. From a technical 
point of view, one of the main problems is the lack of a standard sampling procedure 
and sufficiently accurate measurements for the trace compound analyses. To carry out a 
reliable quantitative analysis, breath samples need collecting in a standard and 
reproducible way. 
 
In the absence of a standardization of the respiratory process and the breath collection 
procedure, the ratio between alveolar air and dead volume can vary a lot from breath to 
breath, leading to a large variability in the data. 
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Breath collection can be performed in two principal ways: mixed sampling and        
end-tidal sampling. In mixed breath sampling all the expired air is collected, including 
the air in the superior airways, which are not involved in a gas exchange (dead volume). 
In end-tidal sampling, only end-tidal air (principally alveolar air) is collected, which 
contains most of the information regarding compound composition in blood. 
Mixed sampling is generally preferred for its simplicity, although dilution by dead 
volume air (15-20%), may depends on the general condition of a person, such as 
pulmonary capacity, pulmonary ventilation and blood flow6, 15, 55, 54. Pulmonary 
capacity varies according to age, gender, build. Thus in the case of mixed breath 
sampling it is important to normalize the data on CO2 concentrations. The amount of 
CO2  in alveolar air during respiration, together with that present in mixed breath 
sample, enables us to evaluate the dilution factor due to the dead anatomical      
volume6, 55, 56. 
 
It would be useful to be able to collect dead volume and end-tidal during the expiratory 
phase separately, because it would enable us to identify the origin of the compounds in 
breath. The presence of exogenous (substances coming from ambient air) compounds, 
in fact, is one of the main sources of pollution. It would therefore be useful to 
distinguish them from endogenous compounds (substances produced from physiologic 
or pathologic metabolism). 
 
The solution to this problem is dealt with in different ways: Phillips asserts that every 
compound needs to be quantified on the basis of the concentration gradient between 
breath and ambient air57; instead Schubert et al., assert that those compounds whose 
concentration in ambient air is comparable or higher than in breath, do not have to be 
considered in the characterization of the subject's breath58; and finally, to get round the 
problem, other scientists, give pure air59, 60 to the subject. In reality this latter solution is 
also questionable, in fact, after exogenous compounds have reached pulmonary alveoli 
dissolved in blood on the basis of their blood/air repartition coefficients, the compounds 
are then transferred through the body and released in the different tissues depend on the 
chemical affinity. The concentration of each compound in alveolar air is the result of a 
dynamic equilibrium that involves several compartments, each with its specific time 
constant. It has been demonstrated that different compounds have different elimination 
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times ranging from minutes to hours61, and this limits the use of pure air only to a few 
cases.  
 
Further complications depend on the water solubility of some exogenous compounds, 
which dissolve in the mucus layer of the upper airways, and are thus present in breath 
in unpredictable amounts62. At the same time, it is known that some endogenous 
compounds of clinical interest, such as nitric oxide, are produced in the superior 
airways and do not come from alveolar air63.  
All these considerations lead to the conclusion that separating the different breath 
fractions could be an effective for future research in this field. 
 
There are many different sampling techniques for breath analysis. Several containers 
are used to sample exhaled air, such as glass tubes and plastic bags, from which a    
sub-sample is transferred directly to the analysis system by means of syringes, or solid 
adsorbents, from which the components are thermally desorbed32.  
 
Several plastic materials were used in gaseous sampling field; among these the most 
used are Tedlar, Nalophan and the Cali-5-Bond, a multilayer material. 
Tedlar is a polyvinylfluoride film with excellent chemical, electrical properties and a 
high mechanics resistance. Furthermore Tedlar material has the property to be a barrier 
at UV rays.  
 
Nalophan (polyethylenterepthalate, PET) is a waterproof material and it is principally 
used in foods storage. It resists against most of the organic solvent, oils, weak acids and 
corrosive solutions; it also resists to temperature between -60°C and 220°C and it can 
not be welded. 
The Cali-5-bond is composed by an internal layer of high density polyethylene, 
followed by polyamide, an aluminum sheet, which avoids diffusion processes, a 
polyvinylidenchloride layer and the last external layer a polyester film. This material 
was specifically projected for the sampling, the transport and the storage of ambient air 
or gaseous mixtures. This material guarantees a lower permeability and a high 
mechanics resistance, together with high chemical inertia.  
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Several types of sampling devices54, 64, 31, 35, 37 have been proposed to guarantee efficient 
sampling that will truly represent the content of exhaled air during the exhalation time, 
some of which are commercially available.  
Pleil et al. collected breath in preconditioned stainless steel canisters56, 65. The subject 
controls the sampling, manually opening the valve through which the breath enters. The 
subject breathes ambient air and mixed samples are collected.   
 
There are two commercially available samplers that permit end-tidal breath to be 
collected. The Quintron system which consists of a tee connector, connected to two one 
way valves. The heart of each valve is a silicon disc that seals the exit until the 
threshold pressure is reached. The valves are regulated to open at different pressures; a 
250 ml bag is connected to the valve that opens at the lowest pressure, whereas a 750 
ml bag is connected to the other valves. There is a mouthpiece at the entrance of the tee 
connector. When the subject breathes in the system, the pressure of the connector 
increases until the first valve opening and the bag are filled with dead volume air. The 
pressure increases again until the second valve opening and the second bag are filled 
with end-tidal breath. 
 
The other collection system, BioVOC™, is produced by Markes International. In this 
case the subject is asked to breathe through a mouthpiece into an open cylinder. Only 
the last portion of end-tidal breath (150 ml) remains in the cylinder after expiration. The 
mouthpiece is then replaced by a piston, used to push the sample in an adsorption tube 
connected to the end part of the cylinder66. 
Even if these systems are not the best solution, they are favourable in terms of their 
simplicity and cost. Their main limitations are the poor control of sampling conditions 
and the low volume collectable with a single breath. 
 
A more sophisticated system, namely Breath Collecting Apparatus was developed by 
Menssana Research57. In this system the subject breathes through a mouthpiece in an 
instrument consisting of an inlet valve for ambient air inspiration and an exit valve 
connected to an open, stainless steel, cylindrical container held to 40°C to avoid water 
condensation. The sampling port, close to the mouthpiece, is connected to an adsorption 
tube, a flow meter and a pump. The system is controlled by a microprocessor, which, 
when necessary, starts the pump. The selective collection of end-tidal air in the 
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container is obtained by starting the pump at an appropriate time interval after 
expiration. The total volume collected in the adsorption tube during multiple breaths 
can be selected by the operator. 
 
A breath sampler with CO2 control has been proposed by Schubert et al. for patients 
who are mechanically ventilated67. When the percentage CO2 volume exceeds the 
expected value an infrared sensor sends the data to an electronic processor, which 
activates a two way valve directing the flow towards an adsorbent trap55. 
 
As regards the commercially available sampler, it is worth noting that BioVOC does 
not have a system to hold the temperature at a specific value to avoid water 
condensation, moreover the cylinder has a small hole into which the subject breathes, 
which causes high back pressure, making the sampler not suitable for subjects with 
pulmonary dysfunctions. 
The same limitations apply to the Quintron system. Although the first bag volume can 
be modified on the basis of the weight and height of the subject, the different 
pulmonary capacities are not considered. The sampler offers a lower back pressure to 
the breathing respect to BioVOC sampler, but no remedy is taken for water 
condensation. 
M. Phillips, on the other hand created a good prototype sampler. The device is built 
with inert materials, uses a disposable mouthpiece and is heated to avoid sample 
condensation, however only a portion of alveolar air is sampled (when the pump is 
sucking) and not all the alveolar air. 
 
From this analysis on breath samplers it is evident that there are many difficulties to 
overcome: back pressure during the expiration phase, sample condensation and an 
accurate separation of the two breath fractions. 
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1.7   Analytical techniques used for chemical breath characterization 
 
The methodologies described in the literature can be divided in two main groups: 
• Analytical techniques providing a sample collecting phase and subsequent 
analysis using different instrumental techniques; 
• Analytical techniques providing an analysis in real time directly on the patients 
using dedicated equipments. 
 
Gaschromatography is certainly the best technique for the separation and the analysis of 
volatile organic compounds (VOCs) in liquid and gaseous samples and coupled with 
mass spectrometry (MS) it enables us to identify analytes in complex mixtures.  
 
After collection the pre-concentration of the analytes is required, because of the very 
low concentration levels in the breath sample. The pre-concentration of the compounds 
can be performed with thermal adsorption tubes, through which a known volume of the 
sample is passed through (Solid Phase Extraction, SPE), or using the solid-phase micro 
extraction technique (SPME)92, 93, 94. 
 
Information on breath composition can also be obtained from direct breath 
measurements performed by different mass spectrometric techniques: Selected Ion 
Flow Tube 68, 69, 70  (SIFT) or Proton Transfer Reaction Mass Spectrometry 71, 72, 73, 74 
(PTR-MS). These techniques enable us to eliminate the collection and pre-
concentration phases and give real time responses. 
 
The SIFT technique was recently applied in the identification and quantification of 
gases present in air and breath samples. A primary ion current (i.e. H3O+) is generated 
from an ionic source. A quadrupole mass filter directs the primary ions into a tube, 
where a flow of an inert carrier gas such as helium is passed through. Most of the 
organic substances have a greater proton affinity than water, thus the H3O+ ion is a 
proton donor.  
The gaseous sample, introduced in the tube, interacts with the primary ion stream; the 
collision between molecules causes the transfer of the proton from primary ion to the 
analyte, which receives a positive charge without any fragmentation. Before reaching 
the detector the produced ions are separated from each other and from the primary ion 
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stream, on the basis of the mass/charge ratio, using a quadrupole mass filter placed at 
the end of the tube. 
 
All the produced ions are detected giving a single mass spectrum. When analyte 
concentrations in the sample are very low, the amounts of primary ions that react are 
lower than the total and the amount of ions produced by the analyte is proportional to 
the partial pressure in the sample73,74. 
 
The PTR-MS technique is similar to SIFT and is shown in Figure 1.5. 
 
 
Figure 1.5  Schema of PTR-MS  
 
An ion source produces H3O+ from water vapour molecules. The H3O+ ions entering the 
drift tube transfer the protons to volatile organic compounds, which have higher proton 
affinities than water.  
 
The exothermic reaction is as follows: 
 
H3O+ + VOC → VOCH+ + H2O                       (4) 
 
The PTR-MS technique is different from SIFT in some ways that are used to increase 
the sensitivity of the method. The system works with an empty cathode ion source, 
which produces a high density of primary ions directing them into the tube without a 
pre selector. Inside the tube only the sample is introduced avoiding dilution from a 
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transport gas. For this reason, an increase of two orders of magnitude in sensitivity can 
be achieved compared to the SIFT technique74. 
 
The two techniques can be used to take frequent and fast measurements without any 
pretreatment of the sample. However, the characterization of the substance only occurs 
on the basis of the mass/charge ratio and the chemical identification of the compounds 
is not easy73, 75, 76. Sometimes gas chromatography separation is needed to perform a 
quantitative, because ions produced from different analytes with the same mass/charge 
ratio can be present73, 74. Another problem is the undesirable fragmentation of the 
sample molecules, which complicate the situation considerably. 
 
In recent years Ion Mobility Spectrometry (IMS) has been developed, which is a small 
and effective instrumentation for the detection of trace compounds in a gases76, 77, 78. 
IMS bases the characterization of compounds on their gas phase mobility, under a high 
electric field. Typically IMS is formed from an ionization chamber with β or a UV 
radiation source, an ion injector, a drift tube and an ion collector. The carrier gas (i.e. 
air or nitrogen) transfers the neutral analyte molecules in the vapour phase into the 
ionization chamber where a series of ion-molecule reactions occur. The reactant ions 
are injected into the drift tube, by periodically opening the shutter grid. The ions 
produced are formed in defined chemical reactions of neutral analyte molecules with 
reactant ions. The mobility of these produced ions may be used to identify the analyte 
molecules. The ions are selectively revealed on the basis of their characteristic drift 
time through the tube. The drift velocity (v) of the ion is related to the electric field 
strength (E) by the mobility (k), where78: 
 
v = k x E                                                (5) 
 
Therefore the mobility is inversely proportional to the drift time, which is usually 
measured at a fixed drift length. In order to work the IMS does not need the vacuum 
and the ambient air may be used as carrier gas. Often the IMS is coupled with a gas-
chromatographic system because, in the case of a complex mixture, the selectivity is 
low70, 71, 76, 77. 
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Recently spectroscopy techniques were developed to determine volatile compounds in 
gaseous samples. The laser spectroscopy technique for example measures the light 
attenuation of the laser after passing through the gaseous sample in the adsorption cell. 
The mid infrared region  (λ=3-10 μm) is particularly interesting, because the vibrational 
transition of most of the organic compounds leads to adsorption lines in that spectral 
range. One of the main advantages of these techniques is the possibility of measuring 
breath components in real time, in pptv (parts per trillion in volume) concentrations. 
Moreover spectroscopy provides information on analyte concentrations in the sample 
during the different phases of respiration. This is different from other analysis 
techniques, which give information on the whole expiratory phase79,70. 
 
 
Alongside traditional analytical techniques, over the last few years innovative 
instrumental techniques based on sensor have been on the increase4, 18, 74, 80, 81. Sensors 
for ethanol and acetaldehyde analysis in breath have been created, immobilizing 
alcohol oxidase (AOD) and aldehyde dehydrogenase (ALDH) enzymes on electrodes82. 
Furthermore MOS (metallic oxide semiconductor) gas sensors seem to provide a good 
methodological approach to breath analysis, because of the wide range of detectable 
gases, their high sensitivity, the fast response and the simplicity of the devices 
involved. The poor selectivity of the sensor is a limitation that may be overcome with 
the use of an array of non selective sensors. The simultaneous use of more than one 
sensor and the application of a multivariate analysis of the data enable us to obtain 
useful information on the chemical composition of the sample. This is despite the fact 
that the sensor array response is not univocally related to the concentration of a single 
compound, but rather to the combination of all the compounds in the breath sample83. 
Recently these sensor arrays have been used in the medical field, to diagnose some 
pathologies, such as diabetes, lung cancer, asthma or other respiratory    
inflammations74, 84, 85, 86, 87. 
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1.8   Breath pre-concentration techniques 
 
Owing to the low concentrations of most of the compounds present in human breath 
(order of magnitude μg/l and ng/l), after sampling and before analysis, a pre-
concentration analyte step is required. The methods used in the sampling and the pre-
concentration of breath substances include a chemical method, a cryogenic method2, 3, 5 
and the most diffused adsorptive methods3.  
 
In the chemical methods, breath is usually bubbled through a reagent solution, which 
only captures a specific compound. The method is simple and direct, and the trapped 
sample is easily analyzed by a spectrophotometric technique. The main disadvantages 
are the low sensitivity and the great effort required by the subject to breathe.   
 
In the cryogenic method, breath is passed through a trap immersed in a cryogenic fluid. 
After sampling the trap is heated and the trapped compounds are released and 
transferred to the instrument by a carrier inert gas. 
 
The main problems encountered during the collecting phase are linked to the high 
content of water, a relative humidity > 95%. In the cryogenic method, if the water is not 
removed, the formation of ice clogs the trap3. In the adsorptive method on the other 
hand, the dipolar interactions between the water and the polar analytes reduce the trap 
efficiency of the adsorbent used88.  
To avoid interferences due to water, different resolutions were found which included 
the use of drying agents (Na2SO4 and CaCl2) through which the sample was passed, or 
the use of membranes with adsorbent surfaces (MESI, Membrane Extraction with 
Sorbent Interface)89. These systems are limited due to the possible loss of the analytes 
and the contamination of the sample. 
 
In the adsorptive method, breath comes in contact with a resin, which traps the organic 
compounds of interest. There are two different types of pre-concentration techniques 
that use adsorption in the solid phase: 
• The Solid Phase Micro-Extraction (SPME), which uses fused silica micro-
fiber coated with an appropriate stationary phase; 
• The Solid Phase Extraction (SPE), in which tubes filled with a specific 
adsorbent phase are used. 
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1.8.1  The Solid Phase Micro-Extraction (SPME) 
The solid phase micro-extraction technique, developed by Pawliszyn in 1989, combines 
the collecting and analytes extraction phases in one step. The SPME does not use any 
solvents90, 91 and may be easily coupled with the most diffuse chromatographic 
technique, such as Gas-Chromatography (GC), High Performance Liquid 
Chromatography (HPLC) and Capillary Electrophoresis (CE)90. 
 
The complete system used for SPME is shown in Figure 1.6 
 
 
Figure 1.6 SPME system: 1) withdrawn fused silica fiber, 2) stainless steel needle,      
3) holder, 4) silicon septum, 5) spring, 6) tube support, 7) plunger. 
 
The pre-concentration procedure exposes the fiber to the sampler for the time required 
by the analytes to reach equilibrium between the sample and the fiber. At the end of the 
equilibration time, the fiber is inserted in to the gas-chromatography injector and the 
analytes are thermally desorbed.  Consequently the carrier gas then transfers the 
analytes into the column30, 91, 92, 93. 
 
The fiber is coated with a thin stationary phase, made of polymers or a mixture of 
polymers with carbon materials.  Different stationary phases, with different thicknesses 
and polarities are available and have affinities with different classes of compounds. 
Polydimethylsiloxane (PDMS), is suited to non polar compounds, carbowax-
divinylbenzene (CW-DVB) and polyacrylate (PA) are suited to polar analytes and 
polydimethylsiloxane-divinylbenzene (PDMS-DVB) and carboxen-polydimethyl 
siloxane (CX-PDMS) do not have a specific application91, 93 , 94, 95. 
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This technique has several advantages in terms of its applicability to all kinds of 
samples (solid, liquid or gaseous) without needing any particular sample preparation, its 
easiness to use, the speed of the analysis and the possibility to perform a chemical 
qualitative screening of a gaseous sample. The principle disadvantages involve the low 
pre-concentration factor analytes are present at trace levels. It is also limited in terms of 
a quantitative analysis of a complex sample matrix, due to the competition of different 
compounds in the distribution process94, 95. 
 
 
 
 
 
1.8.2  The Solid Phase Extraction (SPE) 
In the solid phase extraction technique, the sample passes through an adsorption tube, 
filled with a suitable stationary phase and the analytes are retained on the basis of their 
chemical-physical properties. (Figure 1.7) 
 
 
Figure 1.7 Adsorption tube used in SPE technique: the tube can be made of stainless steel or 
glass  
 
Carbon is the main constituent of the adsorbent in terms of its high chemical inertness 
and its thermal stability96. 
 
Different kinds of carbon are available: 
• Active carbon 
• Carbon molecular sieve 
• Graphite carbon 
• Porous carbon 
 
 26
Each has different properties and retains different classes of compounds. 
 
Active carbons have a complex superficial structure made up of many functional 
groups: phenolic, carboxylic, aldehyde, ketone , peroxy, quinone and lactone. The 
principle mechanism of interaction includes hydrophobic, hydrogen bond and cationic 
exchanges. Using active carbons the compounds were not able to be completely 
released due to their high affinity with the stationary phase96. 
 
Carbon molecular sieves have a highly porous surface with almost uniform           
micro-porous diameters and a wide superficial area, suited for the retention of organic 
compounds. The adsorption mechanisms include dispersive interaction (London or 
dispersion forces, Van der Waal forces) and strong dipole-dipole interactions96.        
The thermal treatment of graphite carbon eliminates volatile compounds and produces a 
homogeneous surface without micro-pores, where the compounds are adsorbed on the 
basis of their size and shape. Most of the surface has non polar sites (carbon atoms) that 
do not react with molecules containing functional groups, thus dispersive interactions 
were predominant in the adsorption mechanism96. 
 
Porous carbon is produced by impregnating a suitable silica gel with mixed resins of 
phenol-formaldehyde, phenol-hexamine, saccharose or other materials. After 
polymerization inside the silica porous gel, the polymer is transformed in to vitreous 
carbon by heating it to 1000°C. The silica portion is removed in order to form the 
pores. The material is then heated to 2000-2800°C in an inert atmosphere, to fit the 
surface, remove the micro-pores and depending on the temperature, produce a certain 
degree of graphitization. The porous carbon has a homogeneous hydrophobic surface 
and the interactions depend on the final heating and possibly on chemical treatments96. 
 
The choice of which adsorbent phase to use has to be made on the basis of the 
following properties97: 
 
• Functionality: expresses the affinity of the phase for the different organic 
compounds; 
• Chemical inertness: the reaction capacity of the phase in relation to adsorbed 
molecules; 
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• Size and shape of the particles: influence the hydrodynamic conditions of the 
sample that passes into the tube and determines the surface area value; 
• Pores dimension: a high porosity determines a larger total surface area; 
• Surface area: influences the recovery and the reproducibility of the adsorption 
process. 
 
If the sample has a high content of water it is convenient to choose a hydrophobic 
material to limit water interferences. The presence of water could interfere with the 
detector acquisition, modify retention time and cause the column to deteriorate 
(referred to the chromatographic technique)98, 99. 
 
The use of a multi-bed tube is recommended if the sample contains compounds with 
different chemical-physical properties. (Figure 1.8) 
 
 
Figure 1.8  Multi-bed tube filled with three different stationary phases with different adsorption 
capacities. 
 
The multi-bed tubes are filled with different phases in an increasing order of adsorption 
capacity. With these tubes the range of adsorbed compounds is wider than with the 
mono-phase tube provided the phases are properly chosen. Adsorption tubes are used 
both with gaseous and liquid samples by applying different collecting techniques. 
 
In terms of gaseous samples, the collecting techniques are as follows: 
• Diffusive sampling 
• Active sampling 
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Diffusive sampling or passive sampling is the easiest procedure from an operative point 
of view. The tubes are exposed to the sample, i.e. air, for an established time; volatile 
compounds diffuse in the tubes and the analytes are retained by the adsorption material. 
This kind of sampling takes a long time. Since diffusive sampling can be performed 
with only mono-phase tubes, the simultaneous exposure of tubes filled with different 
stationary phases is required. 
 
In the case of active sampling, a known volume of the sample passes through the 
adsorption tube using a pump, which maintains a constant flow. Active sampling, 
differently from passive sampling, enables the operator to know the amount of sample 
collected in the tube and for the same sampling time, a greater amount of analyte is 
collected. 
 
Multi-bed tubes can be used in active sampling to retain a wide range of compounds 
with different boiling points and polarities, in just one collection. 
 
The sampling flow may vary from a minimum of 10 ml/min to 200 ml/min, the optimal 
flow being 50 ml/min. With a flow under 10 ml/min, the analytes may diffuse along the 
stationary phase and with a flow higher than 200 ml/min, the recovery of the analytes 
may not be complete. 
 
During the collection process, the operator must be certain that all of the analytes 
collected remain in the adsorbent phase. To assure that no analyte is lost during the 
sample collection, the Breakthrough Volume should be considered. 
 
Breakthrough volume is defined as the calculated volume of carrier gas per gram of 
adsorbent resin that causes the analyte molecules to migrate from the front to the back 
of the adsorbent bed, at a specific temperature. This volume defines the adsorption 
capacity of a resin in relation to a specific analyte and depends on the affinity between 
the stationary phase and the considered compound, the amount of stationary phase in 
the tube and the temperature. 
 
A breakthrough volume measurement can be performed flowing a gas with a known 
content of analyte through an adsorption tube connected directly to a detector, which 
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gives the signal in real time. The detector will give no response until the resin traps the 
analyte. When the breakthrough volume is exceeded, the detector will give a response 
proportional to the amount of analyte coming out. (Figure 1.9) 
 
 
Figure 1.9  Percentage trend of the amount of analyte coming out of the tube with 
respect to the volume of gas passing through (Vb is the breakthrough volume) 
 
For example, at a fixed temperature, if the breakthrough volume for an analyte is       
1.0 litre per gram of resin, then the sample should not be purged with more than 500 ml 
of gas, for tubes filled with   1 g of the adsorbent phase. 
The adsorbent capacity of resin is influenced by humidity, thus the breakthrough 
volume will also depend on the sample content of water and its evaluation should be 
carried out in the same humidity conditions as the sample. In fact it is appropriate to 
sample a maximum volume corresponding to 70% of the breakthrough volume (Safe 
Sampling Volume, SSV), because the amount of analyte in the sample and thus the 
breakthrough volume can vary significantly. 
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1.9  Recovery of the analytes after pre-concentration 
 
The recovery of the sample from the stationary phase can be made by extracting a small 
amount of organic solvent, or alternatively by heating the adsorbent phase purging with 
an inert gas (thermal desorption). The absence of solvent enables us to identify the most 
volatile compounds, usually eluted with the solvent. In addition, the cost and the 
disposal of the solvent are eliminated. 
 
The thermal desorption technique allows the volatile compounds linked to the 
stationary phase to be released using a rapid increase in temperature. The analytes are 
thus transferred to the chromatographic column, using a flow of an inert gas as a 
carrier. Although the sample is rapidly heated, the analyte desorption is not as rapid. 
Thus during the transfer to the chromatographic column, a broadening of the 
chromatographic signal can occur, with a consequent loss of resolution. 
This problem is solved in the two stage desorption system; in fact the analytes desorbed 
from the tube are concentrated in a cryogenic packed trap, which has a reduced internal 
volume. The trap is maintained at a low temperature using a Peltier cell, in order to 
adsorb the analyte coming from the tube; the trap is then rapidly heated and in this case 
the desorption process is faster and the transfer to the column is performed with smaller 
carrier gas volumes. The tube and the trap are both desorbed in the opposite direction 
with respect to the flow during adsorption process. (Figure 1.10) 
 
 
 
 
Figure 1.10  Direction of the flow during compound adsorption and desorption of both 
the trap and the tube 
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In order to completely release the analytes from the adsorption tube, to quantitatively 
adsorb the released compounds in the focusing trap and quantitatively transfer the 
analytes into the column using a smaller volume of carrier gas, following parameters 
need to be optimized: 
 
• Packing material of the trap; 
• Tube desorption, focusing and trap desorption temperatures; 
• Desorption flows and times from the trap and the tube. 
 
Since the internal trap can operate at a lower temperature than ambient temperature and 
the volume of gas that passes through is smaller than the volume passing through the 
tube, a stationary phase can be used with a lower adsorption capacity compared to the 
resin filling the tube. 
 
The selection of an appropriate temperature of the tube is required, in order to 
completely desorb the compounds of interest and avoiding their thermal decomposition. 
It is also best not to desorb near the maximum temperature indicated for a specific 
stationary phase. This is to avoid the degradation of adsorbent material and the 
subsequent release of interfering compounds.  
 
During the focusing phase, the internal trap can be cooled up to -40°C, the temperature 
at which most of the compounds are retained. Where there is a high water content in the 
sample, a temperature of around 0°C is required to avoid ice formation with the 
consequent obstruction of the trap. The desorption temperature also has to allow for the 
quantitative recovery of the adsorbed analytes. The temperature limit is the maximum 
provided for the stationary phase used. Trap and tube desorption times may guarantee 
the complete release of the compounds of interest and usually varies from                     
5 to 30 minutes depending on the carrier gas flow and desorption temperature. 
 
The flow of auxiliary gas during tube desorption should be optimized. A low flow 
limits the extraction efficiency from the tube and the desorption time becomes too long. 
An extremely high flow could limit the retention capacity of the trap. Usually flows 
around 30-50 ml/min are suggested. During the transfer from the focusing trap to the 
chromatographic column, the carrier gas flow should guarantee a quantitative and fast 
transfer of the compounds. The lowest compatible flow is 7-8 ml/min. The carrier gas 
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flow through the trap is the sum of the flow into the column and the split injection flow. 
Capillary columns need a split flow of 5-10 ml/min with flow values in the column of 
0.5-2.0 ml /min, to ensure a sufficiently rapid transfer. 
 
One of the application fields of thermal desorption technique includes an environmental 
analysis for the determination of volatile and semi volatile organic pollutants in the 
atmosphere26, in the working environment30, 32, and in the emissions from building 
materials28, 29. It is also widely used for the extraction of VOCs from matrices such as 
solid samples, emulsions and saline solutions, which cannot be injected directly in the 
chromatography. Over the last few years, this technique has also been used in breath 
analysis, in diagnostic application or to evaluate human exposure to toxic substances100. 
A limitation of this technique obviously includes compounds that are not analyzable by 
gas chromatography, compounds that are easily thermally degradable and compounds 
with a high boiling point (C36 hydrocarbons, PAH, etc). 
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CHAPTER 2 
 
 
Materials and Methods  
 
 
 
 
2.1   Description of standard solution preparation 
 
Stock A  
The liquid mixture consisted of eighteen compounds and two labelled internal 
standards,      Toluene-D8 and Isopropanol-D8 in methanol. Labelled isopropanol-D8 
and toluene- D8 (purity 99.8 %) were purchased from ARMAR Chemicals and used as 
an internal standard, without any further purification. 
Isopropanol, 2-butanone, 2-pentanone, hexanal, 2-heptanone, 4-heptanone, heptanal, 
benzaldehyde were purchased from AccuStandard, Inc. Chemical Reference Standard 
(USA). 
Pentane, 2-methylpentane, hexane, 1,1,1,3,3,3-hexafluoro-2-isopropanol, 
dimethylsulphide, acetone, carbon sulphide and toluene puriss p.a. standard for GC 
grade > 99% were purchased from Fluka. Dimethyldisulphide and isoprene puriss p.a. 
for GC grade > 99% were supplied by Sigma- Aldrich, all compounds were used 
without any further purification.  
 
A stock solution consisting of 50 μl of each 18 neat compounds was prepared (SOL 1). 
Stock A was obtained by adding 20 μl of the stock solution and 50 μl of an 
intermediate labelled solution (Stock H) to 10 ml of methanol. Compound 
concentrations are reported in Table 2.1. 
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Table 2.1   Concentration of compounds in Stock A 
 
Stock A Concentration [ng/μl] 
pentane 70 
isoprene 76 
acetone 88 
dimethylsulphide 94 
carbon sulphide 141 
isopropanol 87 
2-methylpentane 73 
hexane 73 
2-butanone 89 
2-pentanone 90 
hexafluoroisopropanol 177 
dimethyldisulphide 116 
toluene 96 
hexanal 91 
4-heptanone 91 
2-heptanone 91 
heptanal 91 
benzaldehyde 116 
  
isopropanol-D8 111 
toluene-D8 118 
 
 
 
Stock B, Stock C and Stock D  
Two solutions were prepared, consisting of 100 μl of twelve neat compounds (SOL 2) 
and 100 μl of thirteen neat compounds (SOL 3) respectively. A stock solution was 
prepared, consisting of 40 μl of SOL 2 and 40 μl of SOL 3 in 20 ml of methanol (Stock 
B) (Table 2.2).  
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Table 2.2   Concentration of compounds in Stock B 
Stock B 
 Concentration of 
compounds in Stock B 
[ng/μl] 
tetrachloroethylene 267 
3-hydroxy-2-butanone 164 
1-butanol 135 
trichloroethylene  245 
benzene  146 
carbontetrachloride 265 
chloroform 247 
ethylacetate 150 
2,3-butandione 183 
1-propanol 134 
acetonitrile 131 
ethanol 133 
pentane 96 
isoprene 105 
acetone 122 
dimethyl sulphide 130 
isopropanol 121 
2-methylpentane 100 
hexane 101 
2-pentanone 124 
hexafluoroisopropanol 246 
dimethyldisulphide 161 
toluene 133 
4-heptanone 126 
m-cresol 158 
 
 
Stock B solution was diluted to obtain Stock C and D (Table 2.3): 
 
Table 2.3   Preparation of Stock C and D   
 Stock C Stock D 
Stock B (ml) 5 1 
Methanol (ml) 5 9 
Dilution factor 1:2 1:10 
 
The concentrations of all compounds in the different stock solutions are reported in 
Table 2.4  
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Table 2.4   Standard solution concentrations 
[ng/μl] Stock B Stock C Stock D 
pentane 96 48 10 
ethanol 133 67 13 
isoprene 105 52 10 
acetone 122 61 12 
dimethylsulphide 130 65 13 
isopropanol 121 60 12 
acetonitrile 131 66 13 
2-methylpentane 100 50 10 
hexane 101 51 10 
1-propanol 134 67 13 
2,3-butandione 183 92 18 
ethylacetate 150 75 15 
chloroform 247 124 25 
carbontetrachloride 265 133 27 
benzene  146 73 15 
trichloroethylene  245 123 25 
1-butanol 135 68 14 
2-pentanone 124 62 12 
hexafluoroisopropanol 246 123 25 
dimethyldisulphide 161 80 16 
3-hydroxy-2-butanone 164 82 16 
toluene 133 67 13 
tetrachloroethylene 267 133 27 
4-heptanone 126 63 13 
m-cresol 158 79 16 
 
50 μl of Stock H consisting of Toluene-D8 and Isopropanol-D8, were added to the 
three standard stock solutions. The concentrations of the internal standard compounds 
in each solution are reported in Table 2.5 
 
Table 2.5   Concentrations of the internal standards in stock solutions B, C, and D 
[ng/μl] Stock B, C, D
Isopropanol-D8 111 
Toluene-D8 118 
 
 
Stock E  
 
A gaseous Stock E sample was obtained by introducing 20 μl of liquid SOL 1 into a 2 L 
glass flask, held at 40 °C. The preparation of gaseous standards was carried out inside a 
oven held at 40°C, to avoid any condensation of the compounds. The corresponding 
concentrations are reported in Table 2.6. 
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Table 2.6 Concentration of compounds in Stock E 
Stock E Concentration [μg/l] 
pentane 348 
isoprene 378 
acetone 439 
dimethylsulphide 470 
carbon sulphide 703 
isopropanol 436 
2-methylpentane 363 
hexane 366 
2-butanone 447 
2-pentanone 449 
hexafluoroisopropanol 887 
dimethyldisulphide 581 
toluene 481 
hexanal 453 
4-heptanone 454 
2-heptanone 456 
heptanal 454 
benzaldehyde 581 
 
 
Stock F 
 
5 μl of both isopropanol-D8 and toluene-D8 were evaporated in a 2 L glass flask, held 
at 40°C, to prepare a gaseous sample for use as an internal standard. The corresponding 
concentrations are reported in Table 2.7. 
 
Table 2.7   Concentration of the internal standards in Stock F 
Stock F flask concentration [ppmv] 
Isopropanol-D8 839 
Toluene-D8 605 
 
 
 
Stock G 
20 μl of stock solution (Stock G) consisting of 100 μl of the neat compounds reported 
in Table 2.8 were vaporized into a 2 L glass flask, held at 40°C.  
5 ml of this gaseous mixture were then introduced into a Nalophan bag filled with 15 L 
of pure air.  
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Table 2.8    Concentration of compounds in the flask and in Stock G. 
 
Compounds Concentration of Stock G  [ppmv] 
Concentration in bag 
[ppbv] 
Acetone 519 173 
Isopropanol 628 209 
Hexane 292 97 
Methylethylketone 423 141 
Dimethyldisulfide 429 143 
Toluene 359 120 
 
 
 
Stock H 
 
An intermediate labelled solution was prepared consisting of 25 μl of isopropanol-D8, 
25 μl of toluene-D8 and 950 μl of methanol. 
 
 
 
 
2.2   Chromatographic, mass spectrometric and thermal desorption 
methods 
 
Samples were transferred into adsorption tubes using a membrane pump (NMP 50, 
SKC  ITALY) at a constant flow rate measured by a soap bubble flow meter, (mod. 
Humonic Inc). 
Thermal desorption (TD) and GC-MS analysis were performed by an automated two-
stage thermal desorption unit (STD 1000, DANI Instrument, Italy) equipped with an 
internal focusing trap packed with 70 mg of Tenax GR (DANI Instrument, Italy), a GC 
device (Trace GC Ultra, Thermo Electron Corporation, USA) equipped with a DB-624 
capillary column (6% cyanopropyl phenyl siloxane and 94% dimethylpolysiloxane), 
(60 m x 0.25 mm x 1.4 μm film thickness, from Agilent J&W) and a quadrupole mass 
spectrometer (Trace DSQ,  Thermo Electron Corporation, USA)  
A description of the conditions used for thermal desorption, chromatographic and 
spectrometric methods is given in Table 2.9, 2.10, 2.11 
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Table 2.9  Chromatographic and mass spectrometric method 
 
MTD 1 
Chromatographic method 
Inlet temperature 200 °C 
Oven temperature ramps 40°C for 10 min; 10 °C/min until 200°C for 5 min 
Column head Pressure 215 KPa 
Inlet mode split 
Split Flow 10 ml/min 
Transfer line temperature 260 °C 
Mass Spectrometric method 
Ion source temperature 250 °C 
Scan mode Full Scan 10-200 amu 
Scan rate 835.1 amu/sec 
Solvent delay 5 min 
 
 
Table 2.10  Chromatographic, mass spectrometric and thermal desorption method 
 
MTD 2 
Chromatographic method 
Inlet temperature 200 °C 
Oven temperature ramps 35°C for 10 min; 4°C/min until 200°C; 20°C/min 
until 250°C for 10 min 
Flow 2.4 ml/min constant flow 
Inlet mode split 
Split Flow 14 ml/min 
Transfer line temperature 260 °C 
Mass Spectrometric method 
Ion source temperature 250 °C 
Scan mode Full Scan 10-200 amu 
Scan rate 345.2 amu/sec 
Solvent delay 0 min 
Thermal Desorption method 
 Tenax GR Carbopack Y, Carbopack B, Carboxen 1003 
Valve and transfer line 
temperature 200 °C 200 °C 
Tube desorption  Temperature 250 °C 330 °C 
Tube desorption Time 5 min 5 min 
Tube desorption Pressure 72 kPa 72 kPa 
Trap focusing Temperature 5 °C -10 °C 
Trap desorption Temperature 250 °C 250 °C 
Trap desorption Time 5 min 5 min 
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Table 2.11   Chromatographic, mass spectrometric and thermal desorption method 
 
MTD 3 
Chromatographic method 
Inlet Temperature 200 °C 
Oven temperature ramps 35°C for 10 min; 8 °C/min until 200°C for 0.50 
min; 25 °C/min until 260°C for 5 min 
Column head Pressure 225 kPa 
Inlet mode  splitless 
Split flow 10 ml/min 
Transfer line temperature 260 °C 
Mass Spectrometric method 
Ion source temperature 250 °C 
Scan mode Full Scan 15-200 amu  and SIM 
Scan rate 1801.10 amu/sec 
Solvent delay 5 min 
Thermal Desorption method 
 Tenax GR 
Valve and transfer line temperature 170 °C 
Tube desorption  Temperature 300 °C 
Tube desorption Time 5 min 
Tube desorption Pressure 72 kPa 
Trap focusing Temperature -10 °C 
Trap desorption Temperature 250 °C 
Trap desorption Time 5 min 
 
In Table 2.12 are shown the ions of the compounds that were identified by MS 
operating in selected ion mode (SIM). 
 
Table 2.12   Characteristic ions in SIM mass spectra used in MTD3 
Compound SIM Mass Compound SIM Mass 
pentane 43 1-butanol 56 
ethanol 45 2-pentanone 43 
isoprene 67 hexafluoroisopropanol 99 
acetone 58 dimethyldisulphide 94 
dimethylsulphide 62 3-hydroxy-2-butanone 45 
isopropanol 45 toluene 91 
acetonitrile 41 tetrachloroethylene 166 
2-methylpentane 43 4-heptanone 71 
hexane 57 m-cresol 108 
1-propanol 31   
2,3-butandione 43 Isopropanol-D8 49 
ethylacetate 43 Toluene-D8 98 
chloroform 83   
carbontetrachloride 119   
benzene  78   
trichloroethylene  95   
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2.3   Adsorbent phases 
 
 
Table 2.13   Tenax GR  properties 
TENAX GR (250 mg, supply by SUPELCO) 
Chemical Structure 2,6-diphenylene-oxide polymer resin plus 30% graphite 
Temperature Limit 350 °C 
Affinity for Water low 
Specific Surface Area 24.1 sq. m/g 
Pore Volume 2.4 cc/g 
Average Pore Size 200 nm 
Density 0.55 g/cc 
Mesh size 60/80 mesh 
 
 
Table 2.14  Multi-bed adsorption tube phase properties 
 Carbopack Y Carbopack B Carboxen 1003 
Chemical Structure graphitized carbon black carbon molecular sieve 
Temperature Limit 400 °C 
Affinity for Water Relatively low 
Specific Surface Area 24 sq. m/g 100 sq. m/g 1000 sq. m/g 
Density 0.42 g/cc 0.35 g/cc 0.46 g/cc 
Mesh size 60/80 mesh 40/60 mesh 
 
 
 
Anhydrous sodium sulphate (Na2SO4) was purchased from SKC, magnesium 
perchlorate (Mg(ClO4)2) from SerCon and calcium sulphate (CaSO4) from QuinTron. 
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2.4   Bag materials 
 
Nalophan bags were made from a 20 μm thick roll of Nalophan tube, (Tillmanns 
S.p.a.,Milan). A 50 cm long chunk was cut from the roll, then one end was wrapped 
and closed with nylon cable ties; the other end was wrapped and closed around a Teflon 
tube connected to a valve.  
Tedlar bags (film thickness 10-50 μm) were purchased from SKC (USA) while       
Cali-5-bond bags were purchased from Alltech (Italy).  
Cali-5-bond bags are made from a sandwich foil consisting of five different layers, a 75 
μm polyethylene sheet, in contact with the sample, a 40 μm polyamide layer, a 12 μm 
aluminium foil, a 3–4 μm polyvinyl dichloride (PVDC) and a 12 μm polyester (PTEP) 
as the external layer. 
 
To test CO2 bag stability a 5% CO2 standard gaseous mix, (Sol Group Spa, Milan) was 
used. CO2 bag contents were measured using an infrared sensor (Capnostat Mainstream 
CO2 Sensor, Respironics, USA). 
Ultra pure water used during the experiments was obtained using a PureLab Classic 
Pro, USF Elga instrument. 
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CHAPTER 3 
 
 
Experimental Part  
 
 
 
 
3.1   Effect of instrument tuning  
 
Before any sample analysis, it is necessary to demonstrate that the mass spectrometry is 
operating satisfactorily. The instrument was tuned using one or two calibration 
compounds. Tuning involves adjusting source settings, analyzer settings, and gas flows 
to produce optimal peak intensities.  
Perfluorotributylamine (PFTBA) is used to establish tuning performance prior to the 
analysis of volatile compounds. The calibration gas has a molecular weight of 671, and 
fragment ions over a wide m/z range. The relative abundances of ions must fall within a 
predefined range. PFTBA spectra and ion abundance criteria are shown in Figure 3.1 
and Table 3.1, respectively.101 
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Figure 3.1   PFTBA spectra and molecular structure 
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Table 3.1   PFTBA fragment ions and their relative abundances 
Perfluorotributylamine 
m/z Rel. Abundance m/z Rel. Abundance 
69 100 314 1.8 
72 1.1 414 3.4 
93 1.3 464 4.5 
100 17.7 502 2.6 
114 7.9   
119 13.0   
131 47.9   
132 1.7   
145 1.0   
150 2.8   
164 1.4   
169 4.0   
176 1.5   
181 1.8   
214 1.2   
219 50.7   
220 2.3   
226 1.0   
264 13.4   
 
 
This calibration procedure ensures that all samples are analysed with respect to a 
known mass spectrometer reference point.102  
 
Firstly tune parameters were therefore set. (Figures 3.2 and 3.3) 
 
 
 
 
Figure 3.2   Instrument tune parameters 
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Figure 3.3   Instrument tune advanced setting 
 
 
In order to evaluate instrument tuning maintenance and reproducibility over time, 
repeated direct injections of 1 μl of a standard liquid solution Stock A were  performed 
in the GC/MS during tuning variation. The liquid mixture was composed of eighteen 
compounds and two labelled internal standards compounds, Toluene-D8 and 
Isopropanol-D8. The concentrations of the compounds are reported in Table 2.1 
 
After the instrument was tuned, six injections of Stock A per day were performed for 
two days. The instrument was then tuned again and another six daily injections of Stock 
A were performed for three days. The chromatographic and mass spectrometric 
methods are described in Table 2.9. 
 
The graphs below show peak area trends for Toluene-D8 and Isopropanol-D8    
(Figures 3.4 and 3.5) and their peak area ratio trends (Figure 3.6), during tuning 
variation. 
The measurements taken with the first tuning are highlighted with circles. The shape is 
relative to the tuning (circles: first tuning; squares: second tuning) and the fill is relative 
to the injections performed in different days.  
It is possible to notice that the second tuning (squares) gives higher response respect to 
the first one (circles). 
 
 
 
 46
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
2.0x107
4.0x107
6.0x107
8.0x107
1.0x108
1.2x108
1.4x108
To
lu
en
e-
D
8 
pe
ak
 a
re
a
Number of injections
 
Figure 3.4   Toluene-D8 peak area trends, during instrument tuning variation 
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Figure 3.5   Isopropanol-D8 peak area trends, during instrument tuning variation 
 
 
In Figure 3.6 is reported the Isopropanol-D8 and Toluene-D8 peak area ratio trends, 
which confirm that the instrument response is stable in time. 
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Figure 3.6   Isopropanol-D8 and Toluene-D8 peak area ratio trends, during instrument 
tuning variation 
 
 
Average and relative standard deviation percentage (RSD%) of the two internal labelled 
standard injections are shown in Table 3.2. 
 
Table 3.2  Average and RSD% of Toluene-D8 and Isopropanol-D8, during tuning 
variation 
 
First Tuning 
 Isopropanol-D8 Toluene-D8 Toluene-D8 / Isopropanol-D8 Ratio 
Tuning Average 1.34E+08 7.76E+07 0.58 
Tuning RSD% 5% 4% 2% 
1° Day Average 1.29E+08 7.60E+07 0.59 
1° Day RSD% 3% 3% 2% 
2° Day Average 1.39E+08 7.90E+07 0.57 
2° Day RSD% 4% 4% 2% 
      
Second Tuning 
 Isopropanol-D8 Toluene-D8 Toluene-D8 / Isopropanol-D8 Ratio 
Tuning Average 1.70E+08 8.84E+07 0.52 
Tuning RSD% 3% 4% 2% 
1° Day Average 1.69E+08 8.92E+07 0.53 
1° Day RSD% 3% 4% 1% 
2° Day Average 1.66E+08 8.56E+07 0.52 
2° Day RSD% 4% 4% 1% 
3° Day Average 1.74E+08 9.04E+07 0.52 
3° Day RSD% 0.4% 2% 2% 
      
Total Average 1.56E+08 8.43E+07 0.54 
Total RSD% 12% 7% 6% 
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Figures 3.7, 3.8, 3.9, 3.10 and 3.11 show peak area trends for some of Stock A 
compounds, during tuning variation. For each compound the first figure represents peak 
area trends, the second represents peak area trends normalized to Toluene-D8 (a) and 
the third the peak areas trends normalized to Isopropanol-D8 (b). 
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Figure 3.7   Acetone peak area trends, during instrument tuning variation 
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Figure 3.7a   Acetone peak area trends normalized to Toluene-D8, during tuning 
variation 
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Figure 3.7b   Acetone peak area trends normalized to Isopropanol-D8, during tuning 
variation 
 
Average and relative standard deviation percentage (RSD%) of Acetone injections are 
shown in Table 3.3. 
 
Table 3.3  Average and RSD% of Acetone, during tuning variation 
 
ACETONE 
First Tuning 
  
Peak Area Peak Area Normalized toToluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 6.67E+06 6.54E+06 6.48E+06 
Tuning RSD% 4% 2% 2% 
1° Day Average 6.54E+06 6.55E+06 6.61E+06 
1° Day RSD% 2% 2% 0% 
2° Day Average 6.78E+06 6.53E+06 6.37E+06 
2° Day RSD% 4% 2% 1% 
Second Tuning 
  
Peak Area Peak Area Normalized to Toluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 7.42E+06 7.81E+06 7.56E+06 
Tuning RSD% 4% 2% 3% 
1° Day Average 7.62E+06 7.96E+06 7.82E+06 
1° Day RSD% 5% 1% 2% 
2° Day Average 7.19E+06 7.79E+06 7.45E+06 
2° Day RSD% 3% 1% 1% 
3° Day Average 7.45E+06 7.68E+06 7.40E+06 
3° Day RSD% 0.3% 2.1% 0.4% 
    
Total Average 7.13E+06 7.33E+06 7.15E+06 
Total RDS% 7% 9% 8% 
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Figure 3.8   Isopropanol peak area trends, during instrument tuning variation 
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Figure 3.8a   Isopropanol peak area trends normalized to Toluene-D8, during 
instrument tuning variation 
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Figure 3.8b  Isopropanol peak area trends normalized to Isopropanol-D8, during 
instrument tuning variation 
 
Average and relative standard deviation percentage (RSD%) of Isopropanol injections 
are shown in Table 3.4 and 3.4a. 
 
Table 3.4  Average and RSD% of Isopropanol, during tuning variation 
 
ISOPROPANOL 
First Tuning 
  
Peak Area Peak Area Normalized to Toluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 9.30E+07 9.11E+07 9.01E+07 
Tuning RSD% 7% 5% 3% 
1° Day Average 8.71E+07 8.73E+07 8.80E+07 
1° Day RSD% 2% 1% 1% 
2° Day Average 9.78E+07 9.42E+07 9.19E+07 
2° Day RSD% 5% 3% 2% 
Second Tuning 
  
Peak Area Peak Area Normalized to Toluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 1.19E+08 1.25E+08 1.21E+08 
Tuning RSD% 4% 2% 1% 
1° Day Average 1.19E+08 1.24E+08 1.22E+08 
1° Day RSD% 3% 1% 1% 
2° Day Average 1.14E+08 1.24E+08 1.19E+08 
2° Day RSD% 4% 1% 1% 
3° Day Average 1.23E+08 1.27E+08 1.22E+08 
3° Day RSD% 0.6% 2.4% 0.4% 
    
Total Average 1.09E+08 1.12E+08 1.09E+08 
Total RDS% 13% 15% 14% 
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Figure 3.9   Isoprene peak area trends, during instrument tuning variation 
 
 
Isoprene had a trend during tuning variation and the instrument response seemed to 
decrease in time. This is probably referable to the loss of isoprene from the methanol 
solution, due to its high volatility and poor affinity for the solvent.  
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Figure 3.9a   Isoprene peak area trends normalized to Toluene-D8, during instrument 
tuning variation 
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Figure 3.9b   Isoprene peak area trends normalized to Isopropanol-D8, during 
instrument tuning variation 
 
Average and relative standard deviation percentage (RSD%) of Isoprene injections are 
shown in Table 3.5. 
 
Table 3.5 Average and RSD% of Isoprene, during tuning variation 
 
ISOPRENE 
First Tuning 
  
Peak Area Peak Area Normalized to Toluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 1.18E+07 1.16E+07 1.15E+07 
Tuning RSD% 5% 6% 7% 
1° Day Average 1.22E+07 1.22E+07 1.23E+07 
1° Day RSD% 5% 3% 2% 
2° Day Average 1.15E+07 1.10E+07 1.08E+07 
2° Day RSD% 4% 1% 2% 
Second Tuning 
  
Peak Area Peak Area Normalized toToluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 9.95E+06 1.05E+07 1.02E+07 
Tuning RSD% 11% 11% 12% 
1° Day Average 1.12E+07 1.17E+07 1.15E+07 
1° Day RSD% 6% 3% 4% 
2° Day Average 9.77E+06 1.07E+07 1.02E+07 
2° Day RSD% 5% 1% 3% 
3° Day Average 8.83E+06 9.10E+06 8.78E+06 
3° Day RSD% 3.3% 2.0% 3.4% 
    
Total Average 1.06E+07 1.09E+07 1.07E+07 
Total RDS% 12% 10% 12% 
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Figure 3.10   2-pentanone peak area trends, during instrument tuning variation 
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Figure 3.10a   2-pentanone peak area trends normalized to Toluene-D8, during 
instrument tuning variation 
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Figure 3.10b   2-pentanone peak area trends normalized to Isopropanol-D8, during 
instrument tuning variation 
 
Average and relative standard deviation percentage (RSD%) of 2-pentanone injections 
are shown in Table 3.6. 
 
Table 3.6 Average and RSD% of 2-pentanone, during tuning variation 
 
2-PENTANONE 
First Tuning 
  
Peak Area Peak Area Normalized to Toluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 1.22E+08 1.19E+08 1.18E+08 
Tuning RSD% 5% 2% 2% 
1° Day Average 1.18E+08 1.18E+08 1.19E+08 
1° Day RSD% 4% 1% 1% 
2° Day Average 1.26E+08 1.21E+08 1.18E+08 
2° Day RSD% 5% 2% 2% 
Second Tuning 
  
Peak Area Peak Area Normalized to Toluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 1.48E+08 1.56E+08 1.51E+08 
Tuning RSD% 5% 2% 2% 
1° Day Average 1.50E+08 1.57E+08 1.54E+08 
1° Day RSD% 5% 1% 2% 
2° Day Average 1.42E+08 1.55E+08 1.48E+08 
2° Day RSD% 4% 1% 1% 
3° Day Average 1.53E+08 1.58E+08 1.52E+08 
3° Day RSD% 2.0% 1.9% 1.7% 
    
Total Average 1.38E+08 1.42E+08 1.39E+08 
Total RDS% 11% 13% 12% 
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Figure 3.11   Toluene peak area trends, during instrument tuning variation 
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Figure 3.11a   Toluene peak area trends normalized to Toluene-D8, during instrument 
tuning variation 
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Figure 3.11b   Toluene peak area trends normalized to Isopropanol-D8, during 
instrument tuning variation 
 
Average and relative standard deviation percentage (RSD%) of Toluene injections are 
shown in Table 3.7. 
 
Table 3.7 Average and RSD% of Toluene, during tuning variation 
 
TOLUENE 
First Tuning 
  
Peak Area Peak Area Normalized to Toluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 6.81E+07 6.68E+07 6.61E+07 
Tuning RSD% 4% 1% 2% 
1° Day Average 6.66E+07 6.67E+07 6.73E+07 
1° Day RSD% 4% 1% 2% 
2° Day Average 6.94E+07 6.68E+07 6.52E+07 
2° Day RSD% 4% 1% 2% 
Second Tuning 
  
Peak Area Peak Area Normalized to Toluene-D8 
Peak Area Normalized to 
Isopropanol-D8 
Tuning Average 7.61E+07 8.03E+07 7.77E+07 
Tuning RSD% 4% 1% 2% 
1° Day Average 7.70E+07 8.04E+07 7.90E+07 
1° Day RSD% 4% 1% 1% 
2° Day Average 7.36E+07 8.04E+07 7.70E+07 
2° Day RSD% 4% 1% 1% 
3° Day Average 7.77E+07 8.01E+07 7.72E+07 
3° Day RSD% 1.8% 0.9% 1.6% 
    
Total Average 7.31E+07 7.52E+07 7.33E+07 
Total RDS% 7% 9% 8% 
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During the same tuning a good reproducibility of the injections was obtained, with a 
RSD% < 5%, but every time the instrumental tuning was changed, it was necessary to 
make an instrument calibration with standard solutions. Moreover daily average 
injections gave good results. For some compounds a RSD% of around 5% was obtained 
and if the data were corrected for the internal standard, the RSD% decreased to 2%.  
In any case it was necessary to verify instrument responses every day with a standard 
solution, even during the same tuning. 
 
The normalization of data was differentiated on the basis of m/z fragments chosen for 
quantification. Compounds quantified on m/z in the range of 30 to 60 were normalized 
with respect to Isopropanol-D8 (m/z = 49), compounds quantified on m/z in the range 
of 61 to 120 were normalized with respect to Toluene-D8 (m/z = 98). For example 
acetone was quantified on          m/z = 58 and for this reason it was normalized with 
respect to Isopropanol-D8. Sometimes the normalization made on the basis of the 
quantified ion mass was not confirmed from data obtained in the previous 
measurements. In fact, Toluene quantified on m/z = 91 should be normalized with 
respect to Toluene-D8, but the data obtained during the second tuning (Table 3.7) have 
shown that the variability is lower, normalizing with respect to Isopropanol-D8 then 
Toluene-D8. So in these  cases we had to find the better compromise. 
 
 
 
 
3.2  Selection of the adsorbent phase and evaluation of adsorption tube 
performances  
 
There are varieties of adsorbents used in the field of thermal desorption. Often choosing 
the right adsorbent can be difficult. The aim is to choose one that can retain a specific 
or group of analytes for a specified sample volume. However, just as importantly, the 
adsorbent must also be able to release the analytes during the desorption process. 
Most commonly used adsorbent phases are Tenax TA®, Tenax GRTM, CarbopackTM, 
Carbotraps™, Carboxens™, Carbosieve™.  
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There is no one adsorbent available that can both retain and release all the analytes.103 
The selection of an adsorbent resin for an application is based on a large number of 
variables. 
• Breakthrough Volume Data for Analytes of Interest  
• Bed Volume of Adsorption Tube  
• Affinity of Resin for Water  
• Sample Collection Flow Rate  
• Backpressure in the Adsorption Tube  
• Desorption Temperature Required to Purge off Analytes  
• Gas Volume Required to Purge off Analytes  
• Need for an Initial Purge to Remove Water or other Solvents  
Adsorbent resins such as Tenax® TA, Tenax® GR and a wide variety of activated 
charcoals are widely used to trap and analyse volatile and semi-volatile organics from 
gas, liquid or solid matrix samples. Adsorbent resins are specified in several EPA 
methods for air and water testing.104 
Breakthrough Volume charts are helpful for determining the usefulness of a particular 
resin for a particular analyte or a range of analytes in a group of organics such as 
hydrocarbons or alcohols. However, when comparing different adsorbent resins, the 
amount of data can be somewhat overwhelming. Bar chart histograms comparing the 
different adsorbent resins for a range of analytes of a class of organics were therefore 
developed by Manura J. (SIS Inc.).105 A lot of information is condensed into these 
charts. (Figure 3.12 and 3.13) 
 
The numbers at the top of the chart indicate the number of carbons in the analyte 
carbon chain. The numbers at the bottom of the chart indicate the boiling point of the 
analyte. The chart is divided into 5 vertical bar columns indicating the broad 
classification of analytes as gases, volatile, low boiler, medium boiler or semi-volatile. 
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Figure 3.12   Bar chart histogram comparing the different adsorbent resins for 
alcohols105  
 
 
 
 
Figure 3.13   Bar chart histogram comparing the different adsorbent resins for 
hydrocarbons105 
 
The four horizontal bars of the chart indicate the range of analytes that can be 
effectively analyzed with each of the seven adsorbent resins. In addition, each of the 
horizontal bars is divided into smaller sections, which indicate the temperature required 
to desorb the analytes off the adsorbent resin. 
These charts can be easily used to compare adsorbent resins. For example, the charts 
show that Carbosieve SIII can be used to analyze hydrocarbons between ethane (C2) 
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and hexane (C6). Hydrocarbons greater than hexane can not be desorbed off this resin 
below 400 °C.  
Tenax TA can be used to analyze hydrocarbons between pentane (C5) and tetracosane 
(C24). Hydrocarbons smaller than pentane would not be effectively trapped on Tenax 
TA at room temperature and compounds larger than C24 would not be effectively 
desorbed off this resin at  
300 °C.  
A mixed bed resin of Carbosieve SIII and Tenax TA could be used to analyze 
hydrocarbons from ethane (C2) through tetracosane (C24). 
From these charts, the analyst can determine the optimum resin for a particular 
application or to develop a mixed bed resin to expand the range of analytes that can be 
trapped and analyzed via the purge and trap thermal desorption methods.105 
 
On the basis of this information two different adsorption tubes were tested. One was 
packed with Tenax GR and the other was a multi-bed desorption tube, packed with 
Carbopack Y, Carbopack B, and Carboxen 1003. 
In the literature many examples of the use of Tenax GR for sampling ambient air and 
human breath are reported.106 This porous adsorbent phase can retain large amounts of 
compounds with different chemical properties. In fact it retains alcohols, glycols, 
aldheydes, ketones, hydrocarbons, aromatic compounds and halogens. 
Tenax™ GR is a composite material of Tenax TA and 30% graphite. The resulting 
material gives a higher breakthrough volume for most volatile organics, yet still has a 
low affinity for water. In addition Tenax™ GR maintains its high temperature stability 
up to 350 °C. (Table  2.13) 
These properties make Tenax™ GR an ideal adsorbent for the trapping of volatiles 
from air, water and solid samples. Due to its low affinity for water, Tenax™ GR is 
especially useful for the purging of volatiles from high moisture content samples 
including the analysis of volatile organic compounds in water. Since its density is twice 
that of Tenax™ TA, this enables a larger amount of the Tenax™ GR resin to be placed 
inside the desorption tube, thereby increasing the ability to retain volatiles on a small 
resin bed.101 
 
A number of adsorbent materials have proved useful for trapping organics and for 
desorption particularly using thermal techniques. However, none of these materials 
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individually can fully accommodate a complete range of organic volatilities or 
polarities, and thus they must be used in combination with each other. It is apparent 
from published results, that no single sorbent material is practical for collecting all 
solutes. In some instances this is because the sorbents for example, do not retain low-
molecular mass materials; in other cases it is because the analytes are too strongly 
retained to be easily desorbed off the heavier sorbents (activated charcoal for example). 
Given the lack of a universal sorbent, the best approach was to construct tubes 
containing several different materials to attain the desired collection and desorption 
characteristics, the so co-called multi-bed sorbent, where the principle of sequential 
trapping takes place. The adsorption layers are arranged in such a way that compounds 
with the lowest molecular mass go through the initial layer(s), protect the next layer(s) 
and are trapped on the last layer95. 
The multi-bed adsorption tubes were used in the NIOSH Method 2549 for volatile 
organic compounds screening in the air.107  
These phases have a limited adsorption range, but they can retain small volatile 
compounds, such as C2-C3 hydrocarbons and alcohols, and differently from Tenax™ 
GR, they have a rather affinity for water and maintain their high temperature stability 
up to 400 °C. (Table  2.14) 
 
In order to evaluate the performance of the adsorption tubes, systematic measurements 
were taken with a standard gaseous mixture. 
 
 
 
 
3.2.1   Comparison between several drying agents 
 
Breath samples contain large amounts of water (RH > 90%) that can affect the trapping 
of compounds in the tubes, so it was necessary to test the adsorption efficiency of 
different desiccants.  Anhydrous sodium sulphate (Na2SO4), magnesium perchlorate 
(Mg(ClO4)2) and drierite, (97% anhydrous CaSO4 and 3% CoCl2) were tested.  
In order to evaluate desiccant adsorption efficiency, 20 g of each desiccant were 
introduced into Nalophan bags, and the bags were then filled with breath. The 
desiccants had been in contact with the sample for a couple of hours. Five hundred ml 
of the breath sample were transferred into the multi-bed tube, because Tenax GR is 
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unaffected by water. The chromatographic, mass spectrometric and thermal desorption 
methods are described in Table 2.10. 
Figure 3.14 shows water chromatographic peaks in breath samples obtained from the 
bags with Na2SO4, Mg(ClO4)2 and Drierite. 
 
 
Figure 3.14   Water chromatographic peaks (m/z=18) in breath samples obtained from 
the bags with Na2SO4 (blue; first), Mg(ClO4)2 (second) and drierite (third). 
 
 
The chromatograms underline excellent water adsorption efficiency for magnesium 
perchlorate compared to the other two salts, but show significant losses, about 50% of 
the oxygenate compounds, particularly acetone. (Figure 3.15) 
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Figure 3.15   Acetone chromatographic peaks (m/z=58) in breath samples obtained 
from the bags with Na2SO4, Mg(ClO4)2  and drierite. 
 
 
To conclude, sodium sulphate seemed to be the most appropriate desiccant for our 
purposes, even if there was a minor loss of water. 
 
 
 
 
3.2.2   Determination of breakthrough volumes  
 
In order to simplify the experimental procedure, a solution containing a small number 
of compounds was used for the breakthrough volume measurements, which was 
representative of the class of compounds present in the breath samples. 
In the solution there were alcohols (isopropanol), ketones (acetone and 
methylethylketone), alkanes (hexane), aromatics (toluene) and sulphur compounds 
(dimethyldisulphide). 
Five ml of Stock G were introduced into a Nalophan bag filled with 15 L of pure air. 
The concentration of compounds in the bag is given in Table 2.8. 
Tenax GR and multi-bed adsorption tube breakthrough volumes were evaluated 
transferring increasing volumes (0.25 L, 0.5 L and 1 L) of the gaseous mixture from the 
bags into the tubes (flow 100 ml/min). The sampling bag is heated at 40 °C to prevent 
water condensation. The sample is drawn from the bag, through a desiccant cartridge, 
into the adsorption tube by a pocket pump. The flow is set up on the pocket pump and 
controlled by a flow meter. (Figure 3.16) 
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Figure 3.16  Schematic diagram of sample transfer in the adsorption tube 
 
The operative conditions are reported in Table 2.10. 
 
Tenax GR and multi-bed breakthrough volumes for the compounds in the mixture are 
reported in the figures below. 
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Figure 3.17   Acetone breakthrough volume 
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Figure 3.18   Isopropanol breakthrough volume 
 
 
 
 
 
Figure 3.19   Methylethylketone breakthrough volume 
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Figure 3.20   Hexane breakthrough volume 
 
 
 
Figure 3.21   Dimethyldisulphide breakthrough volume 
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Figure 3.22   Toluene breakthrough volume 
 
 
The data showed that all the compounds had a good linearity (showed by the R2 values) 
in the case of the multi-bed adsorption tubes, whereas in the Tenax GR tubes deviations 
from linearity for volumes over 500 ml were noticed for acetone and isopropanol. 
Multi-bed adsorption tubes seemed to be better in recovery but presented critical issues 
in terms of water.  
Carbon molecular sieves are strong hydrophobic sorbents with micro porous surfaces, 
used as the last and most active layer in multilayer traps, to intercept very volatile and 
polar compounds. Initially, the carbon sieves had the reputation of not sorbing water at 
all, since their hydrophobic surface consisted of carbon atoms. However, both 
laboratory practice and specific studies have since showed that their water sorption 
capacity is surprisingly large and approximates to the micro pores volume.108 
Once the relative humidity surpasses a threshold value, a particular mechanism 
becomes operative, micro pores volume filling. This mechanism was studied 
extensively by Stoeckli for the active carbon–water system.109 It involves water vapour 
condensation inside the micro pores rather than the usual physical adsorption on the 
surface. The faster the water saturation, the less free micro pores are available for 
organics, and the faster the decrease in the adsorption capacity for such compounds.110 
For these reasons Tenax GR tubes were chosen to take measurements. 
 
y = 1E+08x + 2E+06 
R 2  = 0.9986 
y = 1E+08x + 1E+06 
R 2  = 0.9989 
0.0E+00
2.0E+07
4.0E+07
6.0E+07
8.0E+07
1.0E+08
1.2E+08
1.4E+08
0 0.25 0.5 0.75 1 1.25
Sampled volume (l)
C
hr
om
at
og
ra
ph
ic
 p
ea
k 
ar
ea
Multi bed Tenax GR
 69
3.2.3 Blank evaluation of adsorption tubes  
 
In order to verify Tenax GR adsorption tubes and trap blanks, systematic measurements 
were taken on conditioned tubes. 
The aim was to control the conditioning procedure and the storage of the adsorption 
tube after conditioning. Thus the chromatograms below were compared: 
 
1. A tube analyzed immediately after conditioning 
2. A tube analyzed after 6 hours, maintained in the thermal desorption with a black cap 
3. A tube analyzed after 9 hours, maintained in the thermal desorption with a black cap 
4. A tube analyzed after 6 days, maintained in a Nalophan bag with a black cap 
5. A tube analyzed after 6 days, maintained in a Nalophan bag with a screw cap 
6. A tube analyzed after 6 days, maintained in the thermal desorption with a black cap 
7. A tube loaded with a breath sample 
 
 
 
 
 
Figure 3.23   Black cap                Figure 3.24   Screw cap  
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Figure 3.25   Comparison of the seven chromatograms; fixed scale at 1.00 * 106; Mass 
range selected 35-200. 
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In the following Table are reported a list of the compounds present in the 
chromatograms. 
 
 
Table 3.8   Compounds present in chromatograms 
 
COMPOUNDS RT Chromatogram 
acetaldeyde 4.28 4,5,6,7 
2-methylbutane 5.33 4,5,6,7 
pentane 6.06 4,6,7 
ethanol 6.42 4,6,7 
acetone 7.53 4,5,6,7 
isoflurane 8.27 4,6,7 
hexane 11.30 4,5,6,7 
methylethylketone 14.09 6 
2-methyldioxane 16.42 4,7 
benzene 16.92 2,4,6 
isooctane 17.30 2,4,5,6,7 
acetic acid 17.98 2,4,5,6,7 
hepatne 18.01 4,6 
butanol 19.12 4,5,6,7 
toluene 23.22 4,5,6,7 
 
 
 
The chromatograms in Figure 3.25 show that the conditioned tube maintained in the 
thermal desorption with a black cap (chromatogram No.2 and 3), was not contaminated 
in a time span of 9 hours. If a conditioned tube was left in the thermal desorption or in a 
Nalophan bag with a black cap for 6 days (chromatogram No.4 and 6), a comparable 
contamination from room air was detected, but this was negligible when compared with 
the breath samples (chromatogram No.7). 
The best way to store conditioned tubes is to put them in a Nalophan bag, closed with a 
screw cap (chromatogram No. 5). 
Some compounds present in the chromatograms came from ambient air contamination, 
for example isooctane was used as solvent for analytical measurements performed in 
the same room. 
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3.3   Determination of response factors for compounds quantification  
 
Instrumental responses, in particular mass spectrometry detectors could change over 
time and it is not always a good practice to compare compound peak areas. So when a 
large number of samples are collected over a long period, it is necessary to quantify the 
amount of compounds present in the sample to compare them. 
Since breath is a gaseous matrix, a gaseous standard mixture was prepared in order to 
calculate for each compound a response factor (K) and determine its concentration. 
Adsorption tubes were loaded with Stock E and a labelled internal gaseous standard 
mixture, composed of Toluene-D8 and Isopropanol-D8 (Stock F). The response factor 
for each compound was calculated with respect to labelled compounds according to the 
following relation: 
 
iD
Di
CA
CA
K ⋅
⋅=
8
8      (6) 
 
Ai and Ci are chromatographic peak areas (a.u.) and theoretical amounts (ng loaded in 
the desorption tube) of i- compound, AD8 and CD8 are chromatographic peak areas (a.u.) 
and theoretical amounts (ng loaded in the desorption tube) of internal labelled standard 
added (toluene-D8). 
Ai and AD8 were obtained by injecting 250 µl of Stock E and 50 µl of Stock F mixtures 
through a septum into the aspiration flow, during sampling of 250 ml of pure air in the 
adsorption tube. In order to verify response factor accuracy, the concentration of 
compounds in a known gaseous sample was determined. 
A Nalophan bag was filled with 10 L of pure air. Twenty ml of Stock E mixture were 
introduced into the air flow through a septum, whilst the bag was being filled. 
From the bag 250 ml of the sample were loaded into the adsorption tube, and analyzed, 
adding 50 µl of the Stock F through a septum. 
 
Compound concentrations were calculated as follows: 
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Ai is the chromatographic peak area of generic compound (a.u.), AD8 e CD8 are 
chromatographic peak areas (a.u.) and theoretical amounts (ng loaded in the desorption 
tube) of internal standard added (toluene-D8), K is the response factor and V is the 
sampled volume (l).  
 
Table 3.9   Comparison between expected and experimental concentrations of Stock E 
mixture in Nalophan bag. 
 
Compound Expected Concentration [ng/l] 
Experimental 
Concentration [ng/l] 
Recovery 
% 
Pentane 626 618 99% 
Isoprene 700 768 93% 
Acetone 790 760 97% 
Dimethylsulfide 847 931 93% 
Carbon sulfide 1260 1317 97% 
Isopropanol 990 906 94% 
2-methylpentane 653 629 97% 
Esane 659 637 98% 
2-butanone 800 799 99% 
2-pentanone 800 800 100% 
Hexafluoroisopropanol 1618 1821 92% 
Dimethyldisulfide 1046 1147 93% 
Toluene 870 963 93% 
Hexanale 800 712 92% 
4-Heptanone 800 863 95% 
2-Heptanone 800 797 99% 
Heptanale 800 837 97% 
Benzaldehyde 1050 999 96% 
 
 
This calibration method produced good results; in fact experimental concentrations 
were in good agreement with theoretical values within ± 7%. 
 
Some problems were encountered over time in terms of the reproducibility in the 
preparation of gaseous mixtures, so we decided to test liquid solutions, for the 
instrumental calibration and compound quantification. 
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3.4   Instrumental calibration with liquid mixture  
 
In order to avoid compound degradation or reactions, two new liquid stock solutions 
composed of twelve compounds (SOL 2) and thirteen compounds (SOL 3) were 
prepared. A stock solution composed of 40 μl of SOL 2 and 40 μl of SOL 3 in 20 ml of 
methanol (Stock B) was made (Table 2.2). Stock B was diluted in two other solutions, 
according to the schedule in Table 2.3. 
Fifty μl of an internal labelled standard solution in methanol, composed of Toluene-D8 
and Isopropanol-D8 (Stock H) were added to the three standard solutions (Table 2.5). 
To obtain calibration curves Tenax GR tubes were loaded with 1 μl of each standard 
solution. Each point of the calibration was analysed in triplicate. The mass 
spectrometric, chromatographic and thermal desorption methods are reported in      
Table 2.11. 
The acquisitions were carried out in full-scan and selected ion monitoring during the 
same analysis. This enabled us to identify interferences or other compounds not present 
in the standard solutions. (Tables 2.12) 
The data obtained were processed with GC software (Xcalibur). The results in terms of 
the correlation coefficient are reported in Table 3.10 and 3.10 (a). 
 
Table 3.10  Correlation coefficient of each compound present in the solution 
Compounds R squared 
pentane 0,997 
etanolo 0.995 
isoprene 0.998 
acetone 0.998 
dimethylsulphide 0.995 
isopropanol 0.999 
acetonitrile 0.998 
2-methylpentane 0.999 
2,3-butandione 0.999 
ethylacetate 0.999 
chloroform 0.998 
carbonthetrachloride 0.999 
benzene 0.996 
trichloroethylene 0.999 
1-butanol 0.998 
2-pentanone 0.996 
hexafluoroisopropanol 0.999 
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Table 3.10 (a)  Correlation coefficient of each compound present in the solution 
Compounds R squared 
dimethyldisulphide 0.999 
3-hydroxy-2-butanone 0.998 
toluene 0.999 
tertachloroethylene 0.999 
4-heptanone 0.998 
m-cresol 0.855 
 
Correlation coefficient values for most of the compounds were greater than 0.99, which 
confirmed the linearity of the calibration curves in the concentration range considered. 
 
Only the correlation coefficient of m-cresol was < 0.90. In fact the RSD% between the 
three replicates for each point is high. (Figure 3.26) 
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Figure 3.26   Calibration curve for m-cresol 
 
The internal trap desorption efficiency for m-cresol was verified, in order to understand 
the previous results. Three tubes were loaded with 1μl of Stock B. The tubes were 
analyzed maintaining the same tube desorption temperature (300°C), and increasing the 
trap desorption temperature (250°C; 275°C; 300°C). The tubes were desorbed twice. 
(Table 3.11) 
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Table 3.11    m-cresol peak area response, increasing trap desorption temperature 
 Trap Desorption Temperature 
 250°C 275°C 300°C 
First analysis (peak area) 3481198 638861 1499564 
Second analysis (peak area) 5093473 1355890 5387632 
First / Second analysis RATIO 0.68 0.47 0.28 
 
Increasing the trap desorption temperature, the recovery of m-cresol did not increase. 
On the contrary, despite the three tubes were loaded with the same amounts, the area 
counts were significantly different from each other. For each analysis the m-cresol did 
not seem to be released from Tenax GR in the same amounts and most of it was 
released during the second analysis. 
The third tube was then desorbed another three times, with the tube and trap desorption 
temperature at 300°C. Data show that the m-cresol contribute is negligible only to the 
fifth analysis (13% compared to the second analysis) and is retained by TenaxGR in the 
tube. (Table 3.12) 
 
Table 3.12   m-cresol peak area after fifth analysis 
m-cresol  Trap and Tube desorption 
temperature  300°C 
First analysis 1499564 
Second analysis 5387632 
Third analysis 2514613 
Fourth analysis 1252170 
Fifth analysis 693087 
 
For this reason m-cresol was not quantifiable. 
 
In order to evaluate if the non-released m-cresol could interfere with the quantification 
of other compounds, the following analyses were performed: 
- Tube 1 was emptied (to verify trap and thermal desorption line cleaning) 
- Tube C was conditioned (to verify conditioning efficiency) 
- Tube loaded with 1μl of Stock C solution (the tube was analyzed twice, but 
the second one was not acquired) 
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- Tube 2 was emptied (to verify trap and TD line cleaning after analysis of a 
tube loaded with a standard solution) 
 
Different contributes were quantified using the previous calibrations. The percentage 
ratios between the area counts obtained from the two empty tubes and the conditioned 
tube, divided by the area counts obtained from the tube loaded with the standard 
solution are reported in the Table 3.13. 
  
Table 3.13   The contribute percentage of each compound with respect to Stock C 
solution, in the following: Empty tube 1; Conditioned tube; Empty tube 2 
 
 First empty tube Conditioned tube Second empty tube 
Pentane <0.05% <0.05%  <0.05% 
Ethanol 0.1% 0.1% 0.1% 
Isoprene <0.05% <0.05%  <0.05% 
Acetone 7.4% 8.6% 4.1% 
Dimethyldisulphide <0.05% <0.05%  <0.05% 
Isopropanol-D8 0.1% <0.05% <0.05% 
Isopropanol 0.3% 0.2% 0.1% 
Acetonitrile 0.1% 0.2% 0.1% 
2-methylpentane 0.1% <0.05% <0.05% 
Hexane 0.2% 0.2% <0.05% 
1-propanol 0.1% 0.1% <0.05% 
2,3-butandione 0.1% 0.1% <0.05% 
Ethylacetate 0.1%  <0.05% <0.05% 
Chloroform 0.1% <0.05% <0.05% 
Carbon tetrachloride 0.1% <0.05% <0.05% 
Benzene 1.8% 13.0% 0.3% 
Trichloroethylene 0.1% <0.05% <0.05% 
1-butanol 0.2% 0.5% 1.4% 
2-pentanone 0.2%  <0.05% <0.05% 
Hexsafluoroisopropanol <0.05% <0.05% <0.05% 
Dimethyldisulphide 0.1% <0.05% <0.05% 
3-hydroxy-2-butanone 0.1% <0.05% <0.05% 
Toluene-D8 0.2% <0.05% <0.05% 
Toluene 0.4% 0.1% 0.1% 
Tetrachloroethylene 0.3% <0.05% <0.05% 
4-heptanone 0.2% <0.05% 0.1% 
 
 
 77
The data show that after two desorption of the tube loaded with Stock C solution, the 
instrument line and the trap are cleaned (Table 3.13 third column) and m-cresol does 
not interfere, thus it is possible to proceed with the other tube analyses. 
 
Furthermore in a time span of about one month another three measurements of the 
standard solutions were taken on different days. The calibration curves obtained were in 
agreement with the previous one, within 10%. 
 
 
 
 
3.5 Comparison between different sampling bags 
 
Breath can be obtained non-invasively using a variety of fairly simple collection 
techniques.111  
Three types of sample collectors are often used to collect and transport air samples for 
later analysis: glass bulbs, stainless steel canisters and bags.  
However, each collector has several drawbacks. Glass bulbs are fragile, and their 
volume is limited. Canisters are heavy and require a special device for cleaning and air 
sampling. 
They are also considered as expensive equipment for occasional analyses. Bags are 
easy to manipulate and transport but are quite fragile (explosion or puncturing).112 
They are used in different studies: for example, bags have been used to collect exhaled 
air113 from volunteers and also used to sample indoor air114. 
Analytical standards were prepared by volumetric injection into the bags and storage 
stability in three different bags was studied. 
 
Three different bag materials were compared in order to evaluate sample stability and 
the release of interfering compounds from bag walls. (Paragraph 2.4) 
1. Nalophan: polyethylenterephtalate (PET) 
2. Tedlar : polyvinylfluoride (PVF) 
3. Cali-5-bond: five different layers of materials are bonded together to form a 
single, flexible material 140 μm thick. 
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First of all the bags’ background was evaluated by filling the bags with purified air; 
after 30 minutes, 500 ml of the sample from each bag were transferred into Tenax GR 
adsorption tubes. Chromatographic, mass spectrometric and thermal desorption 
methods are described in Table 2.10. Figure 3.27 show the chromatograms of 
Nalophan, Tedlar, Cali-5-bond bag background respectively. 
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Figure 3.27  Nalophan, Tedlar, Cali-5-bond bag background 
 
Nalophan and Tedlar bags released less then Cali-5-bond bag. In Table 3.14 the mainly 
identified compounds for each bag are reported.  
 
Table 3.14   Compounds present in bag background 
Compound RT Bag 
2-methyl-1,3-dioxolane 17.75 Nalophan 
N,N-dimethylacetammide 32.99 Tedlar 
phenol 36.80 Tedlar 
acetone 8.52 Cali-5-bond 
ethylacetate 15.59 Cali-5-bond 
benzene 18.25 Cali-5-bond 
2-ethyl-3-methyl-1-pentene 23.34 Cali-5-bond 
toluene 24.82 Cali-5-bond 
1-metoxi-2-propylacetate 30.75 Cali-5-bond 
2,2,4,6,6-penthamethylpentane 34.88 Cali-5-bond 
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To evaluate sample stability in the bag, a gaseous standard mix of eighteen compounds 
(Stock E) was used. The compounds, with different polarities and volatilities 
represented the molecules in breath and in ambient air.  
 
Twenty ml of Stock E were injected in the flow of pure air while simultaneously filling 
Nalophan, Cali-5-Bond, Tedlar bags with 10 L, 10 L and 30 L respectively           
(Table 3.15). 
 
Table 3.15   Concentration of gaseous standard mix in the bags. 
Concentration in the bags 
Compound Nalophan and Cali-5-Bond  
[ng/l] 
Tedlar  
[ng/l] 
Pentane 696 232 
Isoprene 757 252 
Acetone 879 293 
Dimethylsulphide 940 313 
Carbon sulphide 1407 469 
Isopropanol 872 291 
2-methylpentane 726 242 
Hexane 732 244 
2-butanone 894 298 
2-pentanone 899 300 
Hexafluoroisopropanol 1773 591 
Dimethyldisulphide 1162 387 
Toluene 961 320 
Hexanal 906 302 
4-Heptanone 908 303 
2-Heptanone 911 304 
Heptanal 908 303 
Benzaldehyde 1161 387 
 
The gaseous internal standard mix was prepared injecting 5 μl of Isopropanol-D8 and 
Toluene-D8 in 2 L glass flask. 
Two hundred and fifty ml of the sample were transferred into the adsorption tubes from 
each bag, using a membrane gas pump, see Figure 3.16. Tubes loaded with the sample 
were repeated in triplicate after 3, 6, 24, 48 and 72 hours after the bags had been 
prepared.  
During the transfer of the sample in the tube, 50 µl of the internal gaseous labelled 
standard were added to the aspiration flow. 
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All samples were desorbed from the adsorption tubes and concentrated in an automated 
two-stage thermal desorption, followed by gas chromatographic separation and 
identified in a mass spectrometer. Chromatographic, mass spectrometric and thermal 
desorption methods are described in Table 2.10. 
In the following figures for each time span, the average area count for each compound 
corrected by the internal labelled standard and normalized with respect to the area count 
at time zero are reported. 
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Figure 3.28a   Nalophan bag 
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Figure 3.28b   Nalophan bag 
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Figure 3.29a   Tedlar bag 
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Figure 3.29b   Tedlar bag 
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Figure 3.30a   Cali-5-bond bag 
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Figure 3.30b   Cali-5-bond bag 
 
 
On the basis of these results the following considerations were made: 
a) Nalophan 
- Within 24 hours there were no significant variations, confirmed by the 
ANOVA test  
- Within 72 hours dimethylsulphide, toluene and heptanal showed a 20% loss  
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- The benzaldehyde bag content decreased over time: 20% after 3 hours, 35% 
after 6 hours, 60% after 24 hours, 70% after 48 hours, 80% after 72 hours 
b) Tedlar 
- Within 6 hours acetone, isopropanol and hexanal showed a 20% loss that 
remained constant over the subsequent hours 
- Within 24 hours toluene had a variation of 20%, that remained constant over 
the subsequent hours 
- Within 48 hours hexafluoroisopropanol presented a 30% loss  
- Benzaldehyde showed the same behaviour as the Nalophan bag 
 
c) Cali-5-Bond 
- Within 24 hours there were no significant variations except for acetone 
- Within 48 hours hexanal, heptanal, benzaldehyde, carbon sulphide and 
hexafluoroisopropanol presented a significant variation (25%) 
- After 24 and 48 hours acetone showed signal increases of about 20% and 
then 40%, probably due to a release from the bag’s wall. 
 
In addition CO2 stability in the three bags was tested. The bags were filled with a 5% 
CO2 standard gaseous mix. CO2 bag content was measured immediately and after 1, 3, 
5, 24, 29, 31, 32, 48 hours, with an infrared sensor (Paragraph 2.4). Each measurement 
was taken by pumping the sample from the bag through the sensor. The bag volumes 
were 6 L for the Nalophan bag, 3 L for the Tedlar bag and 30L for the Cali-5-bond bag. 
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Figure 3.31   CO2 bags trend 
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The data show that CO2 was stable in the Cali-5-bond bag.  For the Nalophan bag, there 
was a decrease of 7% within 40 hours and there was a loss of importance of 50% only 
for the Tedlar bag.  
The drop in content of some compounds in the Nalophan and Tedlar bags was probably 
due to diffusive processes through the bag walls; the variations for the Cali-5-Bond on 
the other hand were linked to the adsorption phenomena. 
 
Table 3.16   Summarizing table of bags of different materials 
 Background Sample stability Handy Cost 
Nalophan GOOD GOOD GOOD CHEAP 
Tedlar GOOD GOOD GOOD EXPENSIVE 
Cali-5-bond BAD EXCELLENT GOOD VERY EXPENSIVE
 
The Nalophan bag was chosen for our purposes due to its low background 
contamination and its extremely low cost that enabled it to be disposed of thus avoiding 
any need for cleaning. 
 
 
 
 
3.6   Extension of analytical procedure to samples with high water 
contents 
 
Since breath samples have high water content, measurements of sample stability in 
Nalophan bags were repeated with the same mixture saturated with water.  
To prepare humid samples pure air was bubbled through milli Q water before filling the 
bags. 
Dry tubes, filled with 9 g of sodium sulphate, were used to transfer sample from the 
bags into the adsorption tubes. 
The volume of pure air introduced in the bags was calculated measuring the flow and 
time of filling. Two hundred and fifty ml of the sample were transferred into the 
adsorption tube (flow 50 ml/min). 
Tubes loaded with the sample were repeated after 3, 6, 24, 48 e 72 hours, after bag 
preparation. During the transfer of the sample in the tube, 50 µl of internal gaseous 
labelled standard were added to the aspiration flow. 
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In the following figures for each time span, the average area counts for each compound 
corrected by the internal labelled standard and normalized respect to the area count at 
time zero are reported. 
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Figure 3.32   Stability of the gaseous mixture saturated with water in the Nalophan bag 
 
Within 24 hours for the compound of interest present in breath the variation was around 
15%, so compound storage stability was also confirmed for humidity samples. 
 
 
 
 
3.7   Bags preparation reproducibility 
 
In order to evaluate bag preparation and sampling tube reproducibility, repeated 
measurements on three Nalophan bags were taken. 
Twenty ml of Stock E were transferred into three Nalophan bags during bag filling with 
10 L of pure air (flow 500 ml/min). 
Three tubes were loaded with 250 ml of the sample for each bag. During sample 
transfer, 50 μl of the internal labelled standard gaseous mixture were added 
(isopropanol-D8, toluene-D8). 
In the Tables below are reported the average area counts results obtained for some of 
the compounds present in the mixture. 
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Table 3.17   Total compound area counts average and RSD % 
 Total compounds area counts 
Compounds Average RSD % 
pentane 3.70E+07 4% 
isoprene 3.83E+07 4% 
acetone 1.46E+07 3% 
dimethylsulphide 4.01E+07 5% 
carbon sulfide 1.32E+08 4% 
isopropanol 4.72E+07 5% 
2-methylpentane 4.17E+07 4% 
hexane 3.62E+07 3% 
2-butanone 5.38E+07 5% 
2-pentanone 6.47E+07 5% 
hexafluoroisopropanol 2.87E+07 3% 
dimethyldisulphide 7.47E+07 5% 
toluene 1.22E+08 6% 
hexanal 9.82E+06 7% 
4-heptanone 5.95E+07 5% 
2-heptanone 5.19E+07 7% 
heptanal 1.73E+07 5% 
 
 
Table 3.18   Total average and RSD % of compound area counts corrected by the 
internal labelled standard 
 
 Total compounds area counts 
Compounds Average RSD % 
pentane 3.82E+07 5% 
isoprene 3.96E+07 5% 
acetone 1.51E+07 5% 
dimethylsulphide 4.14E+07 6% 
carbon sulfide 1.37E+08 5% 
isopropanol 4.87E+07 5% 
2-methylpentane 4.30E+07 5% 
hexane 3.74E+07 5% 
2-butanone 5.56E+07 5% 
2-pentanone 6.68E+07 5% 
hexafluoroisopropanol 2.96E+07 5% 
dimethyldisulphide 7.71E+07 6% 
toluene 1.26E+08 6% 
hexanal 1.01E+07 6% 
4-heptanone 6.14E+07 5% 
2-heptanone 5.36E+07 6% 
heptanal 1.79E+07 6% 
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The procedure gave good results in terms of reproducibility, with a RSD% around 6%. 
Not always normalizing the data it is possible to obtain a better reproducibility; in any 
case it is important to control the internal standard in order to avoid errors coming from 
the instrument response. 
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CHAPTER 4 
 
 
Clinical Applications 
 
 
 
 
4.1   Breath variability 
 
Diagnosis of disease is based on physical examination and a number of different tests, 
some of which have standard reference values for normal subjects. These reference 
values are based on thousand of subject. In breath analysis there is also a need to create 
a database of reference values and evaluate inter and intra personal variability in 
healthy people. In fact breath composition is affected by many factors, such as food 
ingestion, physical activity, pulmonary ventilation and blood rate.  
In the literature differences in breath samples between people on a diet and people 
eating regularly have been found. In fact the compounds in food enter metabolic 
pathways, which are then absorbed by the organism. 
Sulphur compounds were found in breath samples from people after garlic or onion 
ingestion. In people who drink, much more ethanol was found than in people who do 
not drink. Brushing teeth could also introduce interferences; in fact toothpaste contains 
compounds such as menthol, traceable in breath. Isoprene concentration was found to 
change with the heartbeat.  
 
We thus decided to study daily and weekly individual breath composition variability in 
two volunteers, in order to evaluate how personal habits influence breath composition. 
In particular the trend in time of the two principal compounds in breath, acetone and 
isoprene was observed. 
 
Ethics and respect of cultural differences, privacy, interests, rights and feelings of 
people has been a primary concern, even beyond compliance to current legislation, 
regulations and ethical codes of conduct. Nobody was asked to give a breath sample 
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that had not been informed regarding the aim and modalities of the present study and 
really willing to contribute. In the initial phase of the study, when breath samples were 
only needed to test the analytical procedure without a real interest for the presence of 
markers, breath samples were obtained from the author or from colleagues who 
spontaneously offered to provide breath samples. 
The large majority of patients were enrolled in the Institute of Clinical Physiology. 
These people are consented when entering the Institute about their willingness to 
provide biological samples for research purposes, and only those who had provided a 
positive answer to the questions were contacted. The studies on markers were approved 
by the Ethical Committee of Pisa University -Hospital, Reference Authority  of Italian 
National Commission of Bioethics and Tuscany Regional Ethical Commission with the 
deliberation n° 2328; written informed consensus was collected from both patients and 
nominally healthy subjects involved in these studies. 
 
Breath samples from the same person were collected in a time span of one week. The 
volunteer had to fill one bag in the morning three hours after breakfast and one in the 
afternoon after lunch. In both cases room air was collected. 
The breath sampling system consisted of a disposable mouthpiece, a one way valve, a 
Nalophan bag and a Teflon tube. (Figure 4.1) The mouthpiece and the one way valve 
were sterilized by the sterilized used in the Institute of Clinical Physiology. The Teflon 
tube enabled us to connect the bag to the adsorption tube in order to transfer the breath 
sample. 
The 10 L Nalophan bags were home made.  A piece of Nalophan was cut from a 1 Km 
Nalophan cylindrical roll, one tip was wrapped to a Teflon tube, the other tip was 
closed with nylon cable ties.  
 
 
Figure 4.1  Breath sampling system: A) disposable mouthpiece; B) a one way valve; 
C)Nalophan bag; D) Teflon tube 
B 
A 
C 
D
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Breath samples were analyzed according to the methods described in Table 2.11. 
 
The following graphics show acetone and isoprene breath trends for the two volunteers. 
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Figure 4.2   Subject 1 acetone trend 
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Figure 4.3   Subject 1 isoprene trend 
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Figure 4.4   Subject 2 acetone trend 
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Figure 4.5   Subject 2 isoprene trend 
 
 
Comparing concentrations and variability of acetone and isoprene in the morning and 
afternoon, in the same subject, it transpired that isoprene did not seem to be affected by 
the ingestion of a meal during the day. Acetone, on the other hand, showed a major 
variability and its concentration in the afternoon was doubled, probably due to the kind 
of meal that the subject had eaten (a greater or lower quantity of carbohydrates, fats or 
proteins). 
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In Tables 4.1 and 4.2 the acetone and isoprene mean concentrations and percentage 
relative standard deviations in the morning and afternoon for each subject are reported. 
 
Table 4.1   Acetone and Isoprene average concentrations and RSD% for Subject 1 
 
 Subject 1 
Day Isoprene [ng/l]  Acetone [ng/l] 
  Morning Afternoon Morning Afternoon 
1 377 272 986 1043 
2 316 200 1059 2434 
3 476 232 972 1658 
4 308 476 799 1415 
5 247 258 939 2828 
6 301 218 1033 1721 
     
Average 337 276 965 1850 
RSD% 24% 37% 10% 36% 
 
 
 
 
Table 4.2   Acetone and Isoprene average concentrations and RSD% for Subject 2 
 
 Subject 2 
Day Isoprene [ng/l]  Acetone [ng/l] 
  Morning Afternoon Morning Afternoon 
1 425 344 1285 3330 
2 356 288 1001 2378 
3 363 399 1186 2345 
4 289 235 780 2024 
5 301 287 952 3414 
     
Average 347 311 1041 2698 
RSD% 16% 20% 19% 23% 
 
 
 
The data confirm that a meal can influence breath composition. For this reason if 
possible, it is better to collect a breath sample in the morning before eating. 
The data show also a wide inter-variability between different people. It is thus 
important to find a parameter that enables us to normalize the data and reduce that 
variability. 
 
In the literature this role is in part given to the carbon dioxide present in breath. In fact 
carbon dioxide is the main product of the respiration process and derives from 
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organisms breaking down sugars, fats and amino acids, thus it is closely connected to 
the metabolism processes. It is the amount, or more exactly the pressure of carbon 
dioxide in the air in the lungs, and therefore also in the arterial blood flowing from the 
lungs, that acts so importantly on the respiratory centre.   In normal conditions the 
volume of air that is breathed is kept in exact proportion to the amount of carbon 
dioxide in the blood.115 
For this reason mixed breath samples were collected from four volunteers on different 
days, measuring bag CO2 content with an IR sensor. (Figure 4.6) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6  Scheme of the system used to measure CO2 bag content. 
 
In Table 4.3 the mean concentration corrected and not corrected by the CO2 bag content 
of different compounds over a time span of three days is reported, with the RSD%.  
The corrected concentration value was obtained dividing the measured concentration 
value for CO2 bag content and multiplying for a CO2 reference value 
 
Table 4.3   Mean compound concentration corrected and not corrected by CO2 bag 
content and RSD%, in a time span of three days 
 
 Normal values Values corrected by CO2 
Compound Average [ng/l] RSD% Average [ng/l] RSD% 
Isoprene 415 39% 365 37% 
Acetone 1053 62% 967 70% 
DMS 15 90% 14 90% 
Isopropanol 23 35% 20 40% 
n-propanol 23 80% 19 70% 
Thermostat 40°C 
Sampling bag 
Na2SO4 cartridge Empty Tube Pump 
Flowmeter 
IR 
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The correction of the compound concentration by CO2 bag content determines a small 
variation of the mean concentration and interpersonal variability, but these few 
measurements didn’t show a significant improvement of the results after CO2 
correction. So the correction was not applied to the data presented in next paragraphs. 
 
 
 
 
 
4.2 Human breath analysis medical applications 
 
The diagnostic methods used in medicine require that a sample of body fluid be taken, 
which is quite invasive and uncomfortable for the donor. Breath analysis should be 
added to medical diagnostic techniques, especially since breath sampling is non-
invasive and totally painless.  The major challenge is to be able to identify and quantify 
the compounds present in breath with sufficient accuracy to be useful in diagnosis, 
despite the relatively simple matrix5. 
The final aim is to find a correlation between a compound in breath and a specific 
pathology, in order to develop sensors able to give fast and accurate responses, in a 
completely non-invasive way.  
Thus preliminary studies on breath analysis application for specific pathologies were 
started. 
 
 
 
 
4.2.1   Diabetes mellitus 
 
In the literature many papers have reported the correlation between blood acetone and 
diabetes mellitus.116,117  
Diabetes mellitus is characterized by high glucose levels in blood (hyperglycaemia) due 
to an abnormal quantity or function of insulin. Insulin is the hormone, produced by the 
pancreas, which permits glucose to enter into cells to be used as source of energy. 
When this mechanism is altered, glucose accumulates in the blood circulation. Once the 
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glucose haematic and renal threshold has been exceeded, the effects of glycosuria 
(glucose in urine) and polyuria (loss of water and electrolytes) appear. 
The organism therefore tries to produce glucose through other metabolic pathways such 
as lipolysis (fat acids oxidation), which causes an increase in ketone bodies in blood 
(acetone, β−hydroxybutyric acid, acetoacetic acid). 
Acetone diffuses from the blood to the lung through the alveolar membrane and is 
usually one of the compounds present in large amounts in breath, due to its volatility. 
This compound should be a breath diabetes marker. 
In order to estimate the performance of the procedure, 32 healthy subject samples and 
20 diabetes patient samples were collected in the morning and analyzed. 
 
Table 4.4    
Control 
Subject 
Age 
range Location
Diabetes 
Patient 
Age 
range Location 
14 male 16 male 11 patients 
18 female 25-63 
Institute 
workers 4 female 50-80 9 ambulatory patients 
 
In Figure 4.7 diabetes breath acetone concentrations are reported in ascending order, 
compared with the average acetone concentrations of healthy people (control group).  
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Figure 4.7   Diabetes acetone concentrations (bars) compared with healthy people 
acetone average concentrations (straight line) 
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Mean breath acetone concentrations in the control group was 1048 ng/l, with a standard 
deviation of 407 ng/l.  The diabetes patients acetone concentration on the other hand 
was 1682 ng/l (1.6 times higher), with a standard deviation of 1216 ng/l. 
Results showed a good difference between controls and average patient acetone 
concentrations, but also show a large variability in acetone breath concentrations. Only 
in a few cases was breath acetone in patients significantly different from breath control 
samples. 
These data make the discrimination between the two groups critical and highlight an 
apparent contradiction with what is reported in the literature, concerning the possibility 
of using these parameters to discriminate diabetes patients from healthy people. 
 
Also isopropyl alcohol was investigated because, as reported in literature this 
compound is related to acetone content in blood.118 It is involved in an 
acetone/isopropanol enzymatic equilibrium, linked to lipolysis and regulated by 
oxidized NAD (NAD+) and reduced NAD (NADH) ratio. 
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Figure 4.8    Enzymatic acetone- isopropanol equilibrium 
 
 
 
Isopropanol concentration in breath of patients and healthy people was determined. In 
Figure 4.9 patients are reported in the same order as the acetone Figure 4.7. 
 97
P1 P7 P5 P14 P6 P10 P11 P8 P17 P12 P18 P16 P9 P15 P13 P20 P19 P4 P3 P2
0
200
400
600
800
1000
1200
Is
op
ro
pa
no
l c
on
ce
nt
ra
tio
n 
[n
g/
l]
Patient ID  
Figure 4.9  Isopropanol breath concentrations in diabetes patients (bars) compared to 
isopropanol average concentrations in healthy people (dot line) 
 
 
The average concentration of isopropanol in diabetes patients was 273 ng/l, 2.7 times 
higher than the control group (74 ng/l). The data in this case also had a high variability. 
In most of the samples there was no correlation between the two compounds. Only in 
one case did a high amount of acetone correspond to an elevated amount of isopropanol 
(P2). Furthermore only few patients had a higher level of isopropanol compared to the 
control group. 
It is possible to conclude that isopropanol is also not capable of discriminating between 
diabetes and healthy people. 
 
On the bases of these unsatisfactory results, a critical evaluation of all steps of the 
procedure was made, particularly on the possibility of contamination. 
 
During breath sampling of another group of diabetic patients, room air samples were 
also collected using a glass cylindrical container. A bag was attached to the top of the 
container and inserted. On the cover there were two holes, one was for the inlet of room 
air and the other was to empty the container, in order to fill the bag. Room air samples 
were transferred from the bag into the adsorption tube and analyzed as breath samples. 
 
From the results acetone was present in the room air but at a lower concentration level 
than the breath concentration levels. Isopropanol on the other hand resulted in a higher 
level compared to the breath samples. (Figure 4.10) 
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Figure 4.10  Isopropanol breath concentrations in diabetes patients (bars) compared 
to isopropanol room air concentrations (circles) 
 
A primary cause of the contamination was found to be the disinfectant used in the 
hospital. In fact one of the principal components of disinfectant is isopropanol.  
 
In order to confirm the existence of the enzymatic equilibrium between acetone and 
isopropanol various measurements were carried out. One volunteer inhaled in different 
days a small amount of acetone-D6 and then isopropanol-D8. 
The aim of these preliminary measurements was to verify the production of a 
compound as a consequence of the exposition of another compound, related by a 
metabolic pathway. 
Breath samples were collected at different times after the exposition in order to evaluate 
the removal kinetics of the compounds. 
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Figure 4.11   Isopropanol-D6 trend after inhalation of acetone-D6 (logarithmic scale) 
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Figure 4.12   Acetone-D6 trend after inhalation of isopropanol-D8 (logarithmic scale) 
   
 
The data show the presence of labelled isopropanol after labelled acetone inhaling and 
vice versa. 
In a time span of two hours it was possible to observe a decay in breath labelled 
compound content.  
In the presence of such a contamination and due to the metabolic relation between 
acetone and isopropanol, it is pretty easy to explain the high variability in acetone and 
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isopropanol breath contents, particularly in subjects exposed for a long time. This 
highlights the importance of understanding the relationship between the presence and 
the cause of a compound in breath. The concentration of a compound from a specific 
metabolic pathway can be altered by exposition to the same compound or to other 
exogenous molecules related to several metabolic pathways. 
 
We decided to follow the acetone breath trend of people submitted to oral glucose tests 
(OGT), in order to evaluate if there could be a correlation between blood glucose and 
breath acetone trends in time. The OGT is a diabetes diagnostic test and monitors 
glycaemia in the subsequent hours after dispensing a known amount of glucose. After 
dispensing glucose, glycaemia rises. Within two hours, in subjects without diabetes, 
glycaemia reduces to 1400 mg/l; if this doesn’t happen the OGT is considered positive 
and diabetes is diagnosed. Sixteen samples were collected from subjects submitted to 
the OGT in day hospitals. Before breath collection, room air was analysed, to be sure 
there was not any contamination. Breath samples were collected before glucose 
dispensing (Time 0) when the subject had gone without eating and after glucose 
dispensing, evenly to blood taking, in order to determine glycaemia.  Acetone breath 
concentration trends and glycaemia values versus time, for different patients are 
reported in the following figures.  
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Figure  4.13  Breath acetone trend and glycaemia blood trend in time during OGT, in 
glycaemia pathological curves 
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Figure 4.14  Breath acetone trend and glycaemia blood trend in time during OGT, in 
glycaemia non pathological curves 
 
 
It was not found a correlation between acetone and glycaemia trend during OGT, but 
the results have shown the capacity of the procedure to appreciate small variation in 
breath composition, in consequence of the glucose dispensing. 
 
 
 
 
4.2.2   Hepatic cirrhosis  
 
Cirrhosis is a condition that causes irreversible scarring of the liver. As scar tissue 
replaces normal tissue, blood flow through your liver is affected. This makes it 
increasingly difficult for the liver to carry out essential functions, such as detoxifying 
harmful substances, purifying the blood and manufacturing vital nutrients.119 When 
damage is so severe that liver function is seriously impaired, a liver transplant may be 
the only option. 
 
Preliminary measurements of the breath of cirrhotic patients were taken. The aim was 
to find the compounds in breath that would enable us to diagnose a possible rejection 
crisis or to monitor recovery of hepatic functionality. 
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Breath samples from 7 cirrhotic patients (6 men and 1 woman, age range 19-63) were 
collected before and after a liver transplant. 
Data show the presence of the anaesthetic (sevoflurane) used during the operation and 
its metabolite (hexafluoroisopropanol) in all breath patient samples120. The graphics 
(Figure 4.14 and 4.15) show the two compounds post-transplant peak area trends. 
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Figure 4.14    Post liver transplant breath sevoflurane trend  
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Figure 4.15    Post liver transplant breath sevoflurane metabolite trend 
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These preliminary results highlighted the capacity of this procedure to follow a 
throughput kinetic (clearance) of an anaesthetic and its metabolite. 
Since hepatic metabolism is the principle pathway of drug elimination and more serious 
hepatic diseases can alter that metabolism, it may be possible to obtain information on 
the recovery of hepatic functionality, following post-transplant anaesthetic metabolite 
breath trends. 
Obviously the procedure needs to be standardized, the patients’ statistics has to be 
greater and it is necessary to compare the anaesthetic metabolite throughput kinetic of 
patients with healthy people. 
This is interesting if we consider that surgeons have only one way to verify liver 
rejection crisis: by a biopsy, which is an invasive technique. 
 
 
 
 
4.2.3   Dialysis  
 
The kidney is an organ with many functions: it eliminates hydrophilic metabolites, 
regulates hormonal functions, maintains the fluid balance and acid-base equilibrium, 
manages calcium and phosphorus metabolism. Renal insufficiency is the inability of the 
kidney to purify the blood effectively.  
Dialysis is a treatment used to manage renal insufficiency; it removes excess liquids 
and uremic toxins, assures the fluid balance and acid-base equilibrium, but partially 
replaces the renal function.  
Haemodialysis is a process that needs vascular access and a machine called artificial 
kidney, which includes the following: peristaltic pump, dialysis filter, dialysis liquid. 
During haemodialysis the patient's blood is drawn using a peristaltic pump and passed 
through a filter dipped into the dialysis liquid. There is an exchange of liquids, uremic 
toxins and electrolytes between the blood and dialysis liquid. At this point the purified 
blood is returned to the patient. The blood purification occurs thanks to three 
phenomena which take place in the dialysis filter, where the blood and dialysis solution 
meet: diffusion, convection and osmosis. A semi permeable membrane (dialysis filter) 
interfaces the blood to a dialysis solution, which has a specific composition to bring 
back uremic toxins. 
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Dialysis filters have pores with different diameters, depending on the membrane type; 
they permit the transfer of water, small and medium size molecules, but stop large 
molecules, such as albumin and plasmatic proteins. 
Usually a patient needs three treatments per week, each one lasts 3-5 hours. The 
parameter used to calculate the end of dialysis is the patient's weight loss. 
The aim of collecting breath from patients before and after dialysis is to evaluate 
whether breath composition changes after dialysis, in order to identify an additional 
parameter to monitor the process. Toxins can be big molecules, such as proteins, but 
also small, such as volatile compounds. Since blood is in equilibrium with alveolar air, 
changes in breath content should be possible. 
 
Breath samples from healthy people were also collected to compare compound 
concentration values of dialyzed patients. 
Only breath compounds that had a concentration considerably higher than room air 
concentration were considered. Compounds present in concentrations higher or 
comparable with those of the breath sample were excluded. 
In the Table 4.5 are shown breath compounds concentration range of healthy people 
and the relative variation coefficient within the group. 
 
 
Table 4.5  Breath concentrations of different compounds in healthy people 
 
Control group Concentration Range [ng/l] Average  [ng/l] CV % 
Isoprene 187-471 295 30% 
Acetone 378-2093 800 74% 
Dimethylsulphyde 2-28 11 81% 
Isopropanol 11-31 16 40% 
n-propanol 5-34 20 70% 
2,3-butandione 1-5 2 53% 
3-hydroxy-2-butanone 0.1-2 0.5 81% 
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Table 4.6  Breath concentrations of different compounds in patients before and after 
dialysis 
 
 P1 P2 P3 
Compounds 
concentration [ng/l] 
before 
dalysis 
after 
dialysis 
before 
dalysis 
after 
dialysis 
before 
dalysis 
after 
dialysis 
Isoprene 110 459 192 309 300 304 
Acetone 391 2183 1208 1656 2419 1136 
Dimethylsulphide 2,1 6,2 3 4,8 10 3,4 
Isopropanolo 43 615 70 430 1363 390 
n-propanolo 1,5 24,4 1,5 17,2 19 1,9 
2,3-butandione 2,7 6,4 10 4,3 20 2,7 
3-hydroxy-2-butanone 4,1 4,9 13 2,1 33 0,7 
 
 
Table 4.6 (a) Breath concentrations of different compounds in patients before and after 
dialysis 
 
 P4 P5 
Compounds 
concentration [ng/l] 
before 
dalysis 
after 
dialysis 
before 
dalysis 
after 
dialysis 
Isoprene 250 270 444 764 
Acetone 1298 664 3682 2220 
Dimethylsulphide 8 1,0 26 33,2 
Isopropanolo 313 277 1962 655 
n-propanolo 3,7 0,0 48 49,7 
2,3-butandione 19 2,6 62 24,0 
3-hydroxy-2-butanone 13 0,6 59 46,7 
 
 
In contrast with our expectation, it was not generally possible to observe a decrease in 
compound breath concentrations after the dialysis. Breaths of different patients seemed 
to have a more similar composition after treatment, and for some compounds a minor 
dispersion of data was observed. This could be due to the fact that after four hours of 
dialysis, their blood had been cleaned, more or less in the same way, and they breathed 
the same air. In fact the room air was not changed during the dialysis, so for four hours 
the patient breathed in what they had breathed out. 
There were only two compounds that decreased after the dialysis, 2,3-butandione and                     
3-hydroxy-2-butanone. (Figure 4.16 and 4.17) These two compounds should become an 
additional parameter to follow the dialysis trend, but to confirm that, a major number of 
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measures have to be done and it also important to understand which metabolic pathway 
they come from. 
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Figure 4.16  2,3-butandione concentration in patient breath before and after dialysis 
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Figure 4.17  3-hydroxy-2-butanone concentrations in patients breath before and after 
dialysis 
 
 
In order to compare data, a statistical analysis was made. The t-Student test was applied 
to concentration values of each endogenous compound to estimate if there was a 
significant difference between the control group and patients before and after dialysis 
treatment. (Tables 4.7 and 4.8) 
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Table 4.7  t-Student test between healthy people and patients before dialysis 
 
 Control group Vs Patients before dialysis 
Compound t 
Degrees of 
freedom 
P (significance 
level) 
Differences between 
observed averages 
p<0.05 
Isoprene 0.3541 9 0.7314 NO 
Acetone 1.2590 9 0.2397 NO 
Dimethylsulfide 0.1292 9 0.9001 NO 
Isopropanol 2.6128 9 0.0281 YES 
n-propanol 0.2673 9 0.7952 NO 
2,3-butandione 2.0519 9 0.0704 YES 
3-hydroxy-2-butanone 2.9306 9 0.0167 YES 
 
 
  Table 4.8 t-Student test between healthy people and patients after dialysis 
 
 Control group Vs Patients after dialysis 
Compound t 
Degrees of 
freedom 
P (significance 
level) 
Differences between 
observed averages 
p<0.05 
Isoprene 0.5156 9 0.6186 NO 
Acetone 1.9184 9 0.0873 NO 
Dimethylsulfide 0.0464 9 0.9640 NO 
Isopropanol 8.7704 9 0.0000 YES 
n-propanol 0.0890 9 0.9310 NO 
2,3-butandione 1.5264 9 0.1613 NO 
3-hydroxy-2-butanone 1.4333 9 0.1856 NO 
 
 
For most of the compounds significant differences were not found between healthy 
people and patients. Isopropanol seemed to be higher in dialyzed patients but only 
because this compound was present as a contaminant in the air of the dialysis room. 
Acetone, as demonstrated in paragraph 4.2.1, is closely related to isopropanol so cannot 
be considered. 
The t-test for 2,3-butandione and 3-hydroxy-2-butanone supported our hypothesis 
confirming significant differences between breath concentrations in patients and 
healthy people before the dialysis and no important differences after. 
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CHAPTER 5 
 
 
Future Developments 
 
 
 
 
5.1   Breath sampling system 
 
In the light of the results obtained so far, it is clear that a breath collection protocol is 
needed. In fact the literature and preliminary measurements highlight that breath intra 
and inter-variability is high, even in healthy subjects. 
In terms of respiration physiology, the volume of expired air can be divided in two 
fractions: dead volume and alveolar air. The former is the air that is inhaled into the 
body when breathing, but is not involved in gas exchange with blood; the latter is the 
air in the pulmonary alveoli and alveolar sacs, where there are oxygen-carbon dioxide 
exchanges with pulmonary capillary blood.121 
Endogenous and exogenous compounds are distributed within these two fractions. 
Relevant information can be obtained not only from the compounds present in the 
alveolar air in blood, but also from the compounds produced in tissues and mucosa of 
superior and inferior airways,  as in the dead volume. 
This considerations lead to the conclusion that the separate sampling of different breath 
fractions could provide a valuable contribution to breath research. When interest is 
focused on blood/air gas exchanges at an alveolar level, a further advantage of separate 
sampling is that it avoids diluting the end-tidal with dead space air. Such a dilution 
varies among different individuals and also in the same individual depending on 
sampling conditions. Thus its variability can prevent a correct quantification of 
compound concentrations in end-tidal air and alter the multivariate data patterns 
obtained in measurement campaigns42. A better reproducibility of data is obtained when 
only the end-tidal fraction of breath is analysed122. Compounds with an alveolar origin 
give higher concentrations in end-tidal samples than in mixed expiratory samples. This 
is a positive effect since low concentration levels of breath markers are always a 
challenge from an analysis point of view6. 
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A prototype for breath sampling (Breath Sampler) was designed and produced in 
collaboration with Loccioni, in Jesi (Ancona, Italy) a company which has worked on 
the same problems.  
This system is based on the same principle as Schubert’s,67 but with different 
modalities. In fact in Schubert’s system, an infra red sensor sends data to a control 
system connected to a two way valve. This valve changes the flow direction when the 
percentage CO2 volume exceeds the set value, directing the sample to an adsorbent trap. 
In the prototype, breath is sampled in a bag and the pre-concentration of analytes in an 
absorption tube is then performed off line. The system integrates a flow meter and a 
carbon dioxide measurement unit based on wavelength modulation spectroscopy. Flow 
direction is controlled by a system of valves that can be triggered by the attainment of 
either volume or carbon dioxide concentration values. A breath by breath calculation of 
the volume of anatomical dead space is achieved using an algorithm implementing 
Fowler’s method, while end-tidal CO2 concentration values can be inferred from the 
CO2 concentration data. The system enables large volumes to be sampled on multiple 
breaths. (Figure 5.1)  
 
 
 
Figure 5.1  Breath Sampler prototype 
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5.1.1   Description of the breath sampler prototype 
 
The prototype was designed to collect different breath fractions separately (dead 
volume and end-tidal) according to a series of demanding constraints. Minimum 
pressure losses (a few ml of water) are required so that subjects do not have to make 
any effort when blowing and the subject's safety has to be ensured from a 
bacteriological and electrical point of view. For the construction, suitable materials 
were chosen to limit the contamination of breath samples, both in terms of the release 
of chemical substances from the wetted parts of various components and in terms of 
memory effects related to cross contamination between different samples 
(absorption/desorption of breath compounds onto wetted internal surfaces). Fast sensors 
control the valves, which enable breath fractions to be separated into different sampling 
bags.  
The interaction of a subject with a machine tends to alter normal respiration, probably 
because the control of respiratory functions changes from the involuntary control centre 
to the voluntary one. Such an alteration also affects dead volume space, which can also 
vary a lot in the same person123, 124, 125. Thus for accurate breath sampling on multiple 
breaths, the volume of dead space for every single action needs to be calculated. 
In addition it is important to hold the entire system at 40 °C to avoid water 
condensation. The schematic diagram in Figure 5.2 represents the sampling system. 
The subject breathes into the sampler through a mouthpiece and an antibacterial filter, 
connected to the carbon dioxide sensor and to the mass flow. (Figure 5.4 a) 
Carbon dioxide concentration is measured by a system based on Wavelength 
Modulation Spectroscopy (WMS), which is a very efficient optical technique in gas 
determination. The CO2 analyzer (laser diode with wavelength emissions at 2004 nm) 
and the flow meter measure in real time (20-50 measures per second) the CO2 breath 
concentration and the flow respectively, in order to accurately draw the curve of CO2 
concentrations as a function of the expired volume.  
Data are obtained on a computer using an acquisition card. The typical CO2 waveform 
of concentration graphic versus time is shown in Figure 5.3. 
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Figure 5.2   Schematic diagram of the Breath Sampler42 
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Figure 5.3  CO2 % trend in time during expiration  
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Figure 5.4 (a)  Schematic drawing of Breath Sampler: the arrows show the air flow 
direction during inspiration. (1) antibacterial filter, (2) flow sensor, (3) laser diode, (4) 
entrance valve of ambient air42 
 
 
 
 
Figure 5.4 (b)  Schematic drawing of Breath Sampler: the arrows show the air flow 
direction during expiration. (5) bag connectors; (A, B, C) the valves open during dead 
volume, end-tidal collection and inspiration42 
 
  
During subject respiration the sampler can be in three positions: (Figure 5.4 b) 
1. Inspiration: Valve C open, valves A and B closed; 
2. Dead volume collection: Valve A open, valves B and C closed; 
3. End-tidal collection: Valve B open, valves A and C closed 
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The solenoid valve C opens to enable ambient air to enter the instrument during 
inspiration, valves A and B open during expiration and control the collection of dead 
volume air or end-tidal air respectively. 
 
The system is controlled by a dedicated software that enables the operator to calibrate 
flow and CO2 sensors, to select different collection modalities, and lastly to visualize 
and save exit data (CO2 concentration, expiration flow and volume values), with a 
graphic interface. 
 There are three different ways to close valve A and at the same time open valve B:  
1. CO2 value modality: attainment of a set-point value for the absolute 
concentration of CO2;  
2. CO2 fraction modality: attainment of a user-defined percentage of end-tidal CO2 
concentration, obtained from the product between CO2 MAX and α, where α is a 
parameter chosen by the operator, and represents a fraction between 0 and 1 of 
the CO2 maximum value recorded in the last respiration cycle;  
3. Fowler method modality: attainment of a specific value of expired volume 
calculated according to the Fowler method from relevant data from the last 
respiration cycle, corresponding to anatomic dead space volume49. 
 
Fowler’s manual estimation of anatomic dead space relies on a tedious graphical 
procedure prone to inaccuracies and errors. 
More recently, an algorithm was proposed for use with real-time computer-assisted 
determinations126, but this approach turned out to be too time consuming for breath-by-
breath calculations. We have developed an algorithm that implements Fowler’s method 
in only few steps.  
 
The difference between the areas of shaded regions A and B is calculated by 
subtracting the area of the baseline rectangle abcd from the area of the region abce 
below the curve of CO2 concentration versus expired volume and subtracting the area 
of the rectangle hdfe and adding the area of the triangle gef to the previous result. 
(Figure 5.5) 
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Figure 5.5 Graphic illustration of the algorithm for the implementation of Fowler’s 
method.  
 
The efficiency of the algorithm used to calculate the anatomic dead space volume was 
determined comparing the results from a number of single breaths with the values 
obtained manually calculating the two areas A and B using the graphic method.  
In Fowler’s manual estimation using a graphical approach, the human assessor draws a 
straight line by fitting the plateau of the curve of CO2 concentration versus expired 
volume; then he/she moves the vertical line back and forth, limiting the shaded regions 
A and B until they have the same area. (Figure 5.5)42 
There is a margin of arbitrariness in the drawing of the straight line, which leads to a 
spread in results obtained by different assessors (or even by the same assessor in 
repeated estimates). 
 
Table 5.1 Comparison of anatomical dead space estimations in data of single breaths 
obtained from five test subjects: proposed algorithm, graphical method (average ± 
standard deviation), absolute and percentage deviations. The standard deviation 
accounts for the variability due to manual estimations of four assessors on the same 
data. 
 
    Dead SpaceVolume (ml)     
Subject ID Algorithm Manual 
Absolute 
deviation (ml)
Percentage      
deviation (%) 
1 232 237 ± 8,5 5 2 
2 144 140 ± 3,5 -4 3 
3 151 140 ± 3,5 -11 8 
4 121 125 ± 5 4 3 
5 179 170 ± 8 -9 5 
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As shown in Table 5.1 the two data sets were in good agreement and did not present 
significant differences.  
 
 
 
 
5.1.2   Preliminary measurements on the Breath Sampler performance 
 
Firstly the flow meter and the CO2 sensor were calibrated. The flow meter was 
calibrated using a primary flow calibrator, while the CO2 sensor was calibrated using a 
certified 5% v/v CO2 gaseous mixture in nitrogen.  
The calibration procedure was conducted as follows: 
• Purified air (without CO2) was flowed through the sampler and the signal value 
was set to zero; 
• The 5% v/v CO2 gaseous mixture was flowed through the sampler and the signal 
was set to 5%. 
The profiles of CO2, flow and expired volume curves versus time were then observed 
for consecutive breaths. (Figures 5.6 a, b, c) 
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Figure 5.6 (a)   CO2 percentage trend in time for consecutive breaths 
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Figure 5.6 (b)   Flow trend in time for consecutive breaths 
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Figure 5.6 (c)   Volume trend in time for consecutive breaths 
 
The data shows that during spontaneous respiration the flow has an irregular trend and 
that a slight increase in CO2 concentration corresponds to a decrease in ventilation in 
the last three respiration cycles. (Figure 5.6 c) 
Better regularity in respiration could be obtained by giving the subject some feedback 
to help them control respiration frequency and volume44. For this reason, in the latest 
version of the software a metronomic signal to synchronize respiration and a graphic 
visualizer of volume in time were added, in order to maintain constant tidal volume. 
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Any sample contamination by the instrument material was evaluated by comparing the 
chemical composition of purified air, with the same air passed through the sampler, 
both collected in Nalophan bags. (Figure 5.7) 
The samples were transferred from the bag to the desorption tube packed with Tenax 
GR and analyzed by TD/GC-MS. (MTD 3, Table 2.11) 
 
 
 
 
Figure 5.7 Comparison between the chromatogram of purified air (a) and the 
chromatogram of purified air passed through the Breath Sampler (b) and collected in a 
Nalophan bag 
 
 
There were no substantial differences in the two chromatograms, the major signals 
being at RT=16.46 min, corresponding to 2-methyl-1.3-dioxolane, a compound released 
from the Nalophan bag and to RT= 24.78 min and RT=31.32 min, which corresponds 
to siloxane from chromatographic column purging. 
Signals at the retention time of the characteristic compounds present in breath were not 
observed. This means that the Breath Sampler does not release compounds at 
measurable concentrations at least in terms of the experimental condition used. 
 
 
 
 
2-mhetyl-1,3-dioxolane
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b 
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5.1.3 Breath collection by the Breath Sampler 
 
Tests to sample different fractions of breath were carried out in a healthy subject. In 
order to simplify and accelerate the experimental work, only isoprene and acetone were 
considered. 
The subject breathed spontaneously into the Breath Sampler and the two breath 
fractions were collected in two different Nalophan bags. The “CO2 fraction modality” 
was used, setting up α= 0.8. One bag was filled with dead volume and the other one 
with the end-tidal. A third bag was filled by the subject breathing directly into the bag, 
in this way a mixed breath sample was obtained. 
A comparison between the chromatograms obtained is reported in Figures 5.7a and 
5.7b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 (a)  Chromatographic peak of acetone (EI, m/z=58) obtained sampling 
different fractions of breath: A) relates to the end-tidal portion; B) relates to the mixed 
breath sample; C) relates to the dead volume fraction. 
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Figure 5.7 (b)  Chromatographic peak of isoprene (EI, m/z=67) obtained sampling 
different fractions of breath: A) relates to the end-tidal portion; B) relates to the mixed 
breath sample; C) relates to the dead volume fraction. 
 
 
These preliminary results showed that the amount of acetone and isoprene in end-tidal 
sample was considerably higher than the amount in the dead volume sample and was 
nearly equal to the mixed breath sample. In the end-tidal sample there was a 20 % 
higher amount of acetone compared to the mixed breath sample and a 70 % higher 
amount compared to the dead volume sample. Instead the increases in isoprene on the 
other hand were 29 % and 80 % respectively. 
This demonstrates the capacity of the instrument to separate the two breath fractions. In 
this case the end-tidal content of acetone and isoprene is similar to the mixed breath 
sample content, due to the low presence of these two compounds in the dead volume. 
However it is not possible to know this information a priori, therefore the best solution 
is to sample the end-tidal separately, also to reduce ambient air contamination. 
 
 
In order to work out if different ways of breathing could change breath composition, 
systematic measurements were made. 
A volunteer was asked to breathe in three different modalities, independently, at close 
intervals in a time span of one hour: 
A) Spontaneously breathing; 
B) Controlled breathing: 3 sec of inspiration and 3 sec of expiration;126 
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C) Deep breathing: an attempt to completely empty the lung for each breath. 
The %CO2 breath trend in time and the CO2% maximum value reached for each breath, 
for the three different breathing modalities are shown in the figures below. 
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Figure 5.8 (a) %CO2  trend in time: Breathing modality A 
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Figure 5.8 (b) %CO2  maximum value for each breaths: Breathing modality A 
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Figure 5.9 (a) % CO2  trend in time: breathing modality B 
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Figure 5.9 (b) %CO2  maximum value for each breathes: breathing modality B 
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Figure 5.10 (a) %CO2  trend in time: breathing modality C 
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Figure 5.10 (b) % CO2  maximum value for each breathes: breathing modality C 
 
For the compounds considered the three different breathing modalities do not affect 
CO2 breath content, as is highlighted by the mean breath CO2 value and the relative 
%RSD. 
The data in Table 5.2 show the concentration of the compounds present in breath 
samples obtained with the different breathing modalities. 
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Table 5.2 Comparison between the compound concentrations in breath samples, 
obtained breathing in three different modalities 
 
  Concentration [ng/l ]  
Compounds A modality B modality C modality Mean %RSD 
Ethanol 40 30 30 30 7% 
Isoprene 360 430 500 430 16% 
Acetone 600 800 1000 800 20% 
DMS 28 35 27 30 14% 
Isopropanol 11 12 10 11 9% 
n-propanol 5 5 5 5 13% 
Pentane 3.0 4.0 3.0 3.0 16% 
Hexane 5.0 5.0 4.0 5.0 10% 
CO2 % bag content 4.2% 3.7% 3.9% 3.9% 7% 
 
The breathing modality does not seem to affect breath compound content, as the data 
are in agreement with a mean RSD% equal to 13 %. 
These results are in contrast with those reported in the literature126, and also with our 
expectations.  
This may be due to several factors regarding the Breath Sampler prototype. From the 
CO2 breath profile it is possible to see that the CO2 value between breaths does not 
return to zero. This is probably due to the fact that part of the internal volume of the 
sampler is poorly ventilated. Laser instability was another of the problems we 
encountered; sometimes during breath sampling the CO2 signal was lost and the valves 
started to open and close randomly. In this case there was no certainty with regard to 
the composition of the collected sample. 
From these preliminary results it is clear that some problems need to be solved in order 
to collect different breath fractions.  
 
Another of the major problems encountered, which caused the exclusion of most of the 
measurements made, was ambient air contamination. It is very important to verify 
ambient air composition before colleting breath samples; if in the ambient air the 
concentration of some compounds of interest is higher than in breath samples the 
interpretation of the results may be wrong. 
The discussion on the best solution to this problem still divides the scientific 
community. Some suggest that each compound should be weighed on the basis of its 
concentration gradient between breath and ambient air 57. Others maintain that 
compounds whose concentration in ambient air is comparable or higher than in breath 
should not be taken into account in the characterization of subjects 58. Finally others 
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suggest that the subjects should be provided with purified air in order to circumvent the 
problem59, 60. In fact, this last solution is also disputable. It has been proved that 
different compounds have different washout periods ranging from minutes to hours61, 
which restricts the usefulness of purified air delivery for the removal of exogenous 
compounds to a very limited number of cases. 
 
All these considerations confirm the importance of standardizing breath collection and 
separating dead volume from end tidal. 
On the basis of the results obtained a new Breath Sampler is in the planning stage in 
order to solve the problems encountered. Breath will be collected directly on the 
desorption tube, a different kind of detector technology will be used and most 
importantly the internal structure will be modified. 
 
 
 
 
5.2 Towards a different breath sample collection 
 
Recently there has been increasing interest in Exhaled Breath Condensate (EBC) 
collection. EBC contains several components; the principal component being 
condensed water vapour.127 This fluid represents nearly all of the volume (>99%) of 
fluid collected in EBC.128 Only a small fraction of the condensate is derived from 
respiratory droplets that are released by turbulent airflow, and possibly by other 
currently not completely understood mechanisms. This fraction can be added to the 
water vapour from anywhere between the alveoli and the mouth.129 Therefore, in EBC 
samples not only volatiles are found, but also several other mediators with no volatile 
characteristics (which can be both hydrophobic and water-soluble molecules) including 
adenosine, isoprostanes, leukotrienes, peptides, cytokines, protons and various ions130, 
131. 
During my PhD I spent two months at the U.S. Environmental Protection Agency 
(EPA) in Durham (NC, USA) in Dr. Joachim Pleil's laboratory. The aim of my research 
was to optimize the analytical methodology for measuring polar volatile organic 
compounds (PVOCs) in EBC samples, in order to detect metabolic responses to 
environmental stressors. In fact environmental exposures, individual activities, and 
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disease states can perturb normal metabolic processes and be expressed as a change in 
the patterns of polar volatile organic compounds present in biological fluids. 
A simple procedure to measure PVOCs in aqueous media was developed and the 
precision and sensitivity of the method were assessed. Lastly different sampling 
methods were compared and applied to a series of human EBC samples to assess the 
variance within a small group of volunteers. 
 
 
 
 
5.2.1 Method development 
 
Neat aldehydes and neat alcohol standards, purchased from Accustandard, were used to 
prepare stock solutions. All standards and blanks were prepared using high purity de-
ionized water. Initial experiments were conducted to assess mass spectrometry 
parameters. 
The compounds used to prepare the stock solutions are reported in Table 5.3. 
 
Table 5.3 Compounds used to prepare stock solutions; 3-hexanol is the internal 
standard 
 
Compounds Density (mg/μl) 
2-methyl propanal 0.793 
butanal 0.802 
3-methyl butanal 0.796 
pentanal 0.818 
1-propanol 0.803 
hexanal 0.814 
2-methyl 1-propanol 0.802 
3-methyl 3-pentanol 0.827 
1-butanol 0.810 
4-methyl 2-pentanol 0.807 
heptanal 0.817 
1-pentanol 0.815 
octanal 0.821 
2-ethyl 1-butanol 0.833 
1-hexanol 0.819 
1-heptanol 0.823 
Average density 0.812 
  
Compounds (IST) Density (mg/μl) 
3-hexanol 0.814 
 
 126
 
The Stock solutions were prepared as follows: 
 
Table 5.4  Stock solution preparation 
 
Stock solution Procedure Concentration 
Stock A 2 μl of each neat compound in 20 ml of water 0.1 μl/ml 
Stock B 2 ml of Stock A in 18 ml of water 0.01 μl/ml 
IST* Stock A 1 μl of neat 3-hexanol compound in 8 ml of 
water 
0.125 μl/ml 
IST* Stock B 2 ml of IST Stock A in 6 ml of water 0.0031 μl/ml 
*Internal Standard 
 
 
Three replicates of a standard solution were run in scan method. Three glass bulbs and 
caps were prepared by washing in a dishwasher and three Tenax TA tubes were 
conditioned, purging with Helium (100 ml/min), at 290°C for two hours. Clean bulbs 
were placed on a slanted rack; ~ 700 mg of NaCl were added, followed by a Tenax TA 
tube.  
1.5 ml of a 200 ppb standard solution prepared from Stock B, was injected into the 
bulbs.  
Samples were allowed to equilibrate with their respective Tenax tubes for 24 hours at 
room temperature. After 24 hours the samples were analyzed by TD/GC-MS. 
Chromatographic, mass spectrometric and thermal desorption methods are described in 
Table 5.5 and 5.5 (a). 
 
Table 5.5  Chromatographic, mass spectrometric and thermal desorption method 
 
MTD 4  
Chromatographic method 
Inlet Temperature 250 °C 
Oven temperature ramps 40°C for 2 min; 10 °C/min until 250°C for 8 min 
Column head Pressure 15 psi 
Inlet mode  splitless 
Transfer line temperature 280 °C 
Column HP-5MS from Restek (30 m x 0.25 mm x 0.25 μm) 
Mass Spectrometric method 
Ion source temperature 250 °C 
Scan mode SIM 
Solvent delay 3.5 min 
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Table 5.5 (a) Chromatographic, mass spectrometric and thermal desorption method 
 
Thermal Desorption method 
 Tenax TA 
Internal trap Water Management from Markes 
Valve and transfer line 
temperature 150 °C 
Dry purge 3 min at ambient temperature 
Tube desorption  Temperature 260 °C 
Tube desorption Time 10 min 
Trap focusing Temperature 0 °C 
Trap desorption Temperature 310 °C 
Trap desorption Time 3 min 
 
From the chromatograms two ion fragment masses were chosen for each compound and 
a SIM method was carried out as follows 
 
 
Table 5.6  Characteristic ions in SIM mass spectra  
 
Group 
No. RT ion ion n° 
Dwell 
Time 
1 3.50-8.00 42 43 44 58 59 72 6 80 
2 8.00-9.30 43 55 56 72 73 74 6 80 
3 9.30-10.80 41 44 45 55 56 59 10 70 
    69 70 87 96         
4 10.80-12.50 42 43 55 57 70 84 6 80 
5 12.5 43 56 69 70     4 100 
 
 
Table 5.7  Compounds present in each group 
 
Group 
No. Compounds 
1 2-methyl propanal; butanal; 3-methyl butanal; pentanal; 1-propanol 
2 hexanal; 2-methyl 1-propanol; 3-methyl 3-pentanol;  
3 1-butanol; 4-methyl 2-pentanol; heptanal; 3-hexanol 
4 1-pentanol; octanal; 2-ethyl 1-butanol     
5 1-hexanol; 1-heptanol       
 
 
Once the method parameters were defined, the linear concentration range was assessed 
using multi-point calibration.  
In order to prepare the calibration solutions, Stock B was diluted as follows: 
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Table 5.8 Calibration  solution schedule preparation. 
 
  Blank Step 1 Step 2 Step 3 Step 4 Step 5 
Stock B (μl) 0 30 100 100 100 100 
Water (ml) 5 30 25 12.5 8 5 
Internal Std B (μl) 15 90 75 37.5 24 15 
Conc IST (ppb) 93 93 93 93 93 93 
Conc Std (ppb)* 0 10 40 80 125 200 
*ρstd was only used for the Stock A calculation. All others were majority water 
 
 
Calibration results in terms of R squared, calculated on the area counts corrected for the 
internal standard are reported in Table 5.9. 
 
Table 5.9  Calibration results in terms of R squared 
 
Compounds Slope Intercept R squared 
2-methyl_propanal 7.63E-04 1.11E-03 0.997 
butanal 7.19E-04 3.51E-03 0.985 
3-methylbutanal 1.21E-03 7.80E-04 0.996 
pentanal 1.37E-03 8.61E-03 0.990 
1-propanol 5.07E-04 -2.49E-03 0.959 
hexanal 1.15E-03 1.30E-02 0.988 
2-methyl-1-propanol 2.82E-03 -7.04E-03 0.994 
3-methyl-3-pentanol 8.64E-03 2.48E-02 0.997 
1-butanol 3.55E-03 -1.45E-03 0.976 
4-methyl-2-pentanol 7.60E-03 3.42E-02 0.993 
heptanal 9.24E-04 9.58E-03 0.990 
1-pentanol 3.15E-03 -5.68E-03 0.991 
octanal 5.34E-04 1.70E-02 0.916 
2-ethyl-1-butanol 4.95E-03 1.23E-02 0.995 
1-hexanol 6.81E-03 -7.93E-03 0.989 
1-heptanol 3.98E-03 -9.79E-03 0.961 
 
The response is linear within the concentration range considered. 
In order to evaluate the precision of the analytical procedure, 10 replicates of two 
different standard solutions were run. 
The estimated method precision expressed as a percentage relative standard deviation 
(%RSD) at two spike levels is reported in the following table. 
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Table 5.10  RSD% for 10 replicates at two spike levels 
 
 % RSD 5ppb 
% RSD 
100ppb 
2-methyl_propanal 12% 10% 
butanal 17% 16% 
3-methylbutanal 21% 17% 
pentanal 18% 18% 
1-propanol nd 18% 
hexanal 38% 33% 
2-methyl-1-propanol 41% 30% 
3-methyl-3-pentanol 28% 32% 
1-butanol 22% 35% 
4-methyl-2-pentanol 41% 34% 
heptanal 34% 35% 
1-pentanol 35% 25% 
octanal 31% 20% 
2-ethyl-1-butanol 43% 28% 
1-hexanol 38% 32% 
1-heptanol 30% 29% 
Mean RSD% 30% 26% 
 
 
The reproducibility of the method was around 30%, which is good if we consider the 
low standard solution concentrations, which are representative of the breath condensate 
compound concentrations. 
 
 
 
 
5.2.2  Exhaled breath condensate collection device 
 
Two different EBC collection devices were tested in order to assess EBC volume 
recovery. 
 
1) EBC samples were collected using a modified R-Tube (Respiratory Research, Inc. 
Charlottesville, VA). The original product was modified and the new one consisted 
of a non-rebreathing valve and a 22 cm length x 2.6 cm diameter tube (Figure 5.11). 
An 8 cm diameter co-axial container (Figure 5.12) surrounding the R-Tube was 
filled with granulated dry ice (-80°C) to chill the R-tube.  
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     Figure 5.11  R-Tube             Figure 5.12  Modified container to chill the R-Tube 
 
 
A seated subject performed the tidal breathing manoeuvre through the device for 10 
min. Upon completion, the R-tube was removed from the valve, capped at both 
ends, extracted from the chilling container and allowed to warm to room 
temperature. The melted EBC was consolidated from the walls of the R-tube using 
an internal o-ring plunger and transferred immediately with a calibrated glass 
syringe to a 4 ml vial, held at -80°C.132 
 
 
2) A second EBC collection device developed in the EPA laboratory was also used. 
Breathing manoeuvres were the same as for the R-tube, whereas with this device, a 
150 cm length x 2 cm diameter Tygon tube immersed in dry ice was used. (Figure 
5.13) 
 
 
Figure 5.13   Schematic diagrams of the exhaled breath condensate collecting device: 
(A) Dry ice; (B) Tygon tube; (C) End of the tube where the subject breathes; (D) One-
way valve, filter and Eco Vent; (E) Polistyrol container 
A
B C
D
E
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After 10 min of breathing, the tube was capped at both ends, with one end using a 10 
ml vial as a termination. The tube was allowed to warm to room temperature and the 
beaded EBC liquid was driven into the vial using centrifugal force (swinging the tube 
in an overhead circle for 1 min). The vial was immediately capped and stored in dry ice 
or in the glacier. 
The end of the tube was connected to a non-rebreathing valve followed by a real-time 
pneumotachograph (EcoVent, Jaeger). EcoVent recorded exhaled breath volume, time 
exhaled, tidal volume (TV), peak expiratory flow, minute ventilation and breathing 
frequency (bf)133, 134. 
 
Since ambient air contains molecules that could influence EBC composition through 
several possible mechanisms, room air was also collected. (Figura 5.14) 
 
 
 
Figure 5.14   Schematic diagrams of ambient air collecting device: (A) Polistyrol box; 
(B) Dry ice; (C) Glass bulb; (D) Teflon tube; (E) Pump 
 
 
Room air was pulled from a pump (9 L/min for 15 min) through the glass bulb 
immersed in dry ice in the box. In this way the air condensed in the bulb. After 
defrosting, the sample was transferred to a vial. 
To decide how long the air should be collected, the following calculations were 
performed: at a temperature of 25°C and a relative humidity of 75%, the air water 
content was 16 g per m3 of air.135 This corresponds to16 ml of H2O / m3, so for a sample 
of 2 ml, it is necessary to collect 0.125 m3 of air → 125 L. 
 
E 
D 
B 
A 
C 
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5.2.3  Human EBC sample collection and analysis 
 
For this preliminary evaluation, 10 samples were collected from volunteers; the idea 
was to compare the two different collection methods, in order to figure out which was 
the best. The data showed that there were no differences between the two collection 
methods regarding breath compound concentrations; the only advantage with the 
second method was the higher recovery in condensate sample volume. (Table 5.12) 
This allowed the sample to be split and run in duplicate, in order to work out the 
reproducibility of the real breath sample. 
 
Table 5.11  Concentrations of compounds found in breath samples, collected with the 
two different methods. 
 Collection method number 1 
Concentrations [ppb] Compounds 
EBC1 EBC2 EBC3 EBC4 EBC5 
2-methyl propanal 3 1 2 3 2 
3-methylbutanal 58 1 1 1 2 
1-propanol 54 146 259 279 349 
2-methyl-1-propanol 2 4 3 4 3 
1-butanol 25 98 42 28 120 
heptanal 3 3 4  5 
1-pentanol 3  0.1   
octanal 0.4 7 15 15 22 
1-hexanol 2 3 4 6 4 
1-heptanol 4 1 2 11 2 
 
 
Table 5.11 (a)  Concentrations of compounds found in breath samples, collected with 
the two different methods. 
 Collection method number 2 
Concentrations [ppb] Compounds 
EBC6 EBC7 EBC8 EBC9 EBC10 
2-methyl propanal 3 3 8 14 4 
3-methylbutanal 75 75 66 66 65 
1-propanol 190 172 66 124 185 
2-methyl-1-propanol 6 32 135 221 23 
1-butanol 5 4 5 3 4 
heptanal 2     3   
1-pentanol 3 4 4 6 3 
octanal 84 1   19   
1-hexanol 2 3 7 2 2 
1-heptanol 4 3 4 4 3 
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Table 5.12  Breath condensate volume collected with the two methods; it was also 
possible to measure the exhaled breath volume, only with the second method. 
 
Sample ID Exhaled  breath volume Breath condensate volume 
EBC 1 nd 1.8 ml 
EBC 2 nd 1.7 ml 
EBC 3 nd 2.1 ml 
EBC 4 nd 1.6 ml 
EBC 5 nd 2.3 ml 
EBC 6 168.2 L 4.5 ml 
EBC 7 175 L 4.2 ml 
EBC 8 122.8 L 4.0 ml 
EBC 9 125.1 L 4.2 ml 
EBC 10 174 L 5.5 ml 
 
 
It is possible to estimate the concentrations only for a few molecules, (Table 5.11) 
because most of the compounds are of a very low concentration, near to the zero point 
of the calibration.  
In fact one of the current limitations of EBC measurements is the low concentration of 
many compounds so that their measurements are limited by the sensitivity of the 
assays. 
Moreover, a comparison of compound concentrations in ambient air and in breath 
shows that they are similar to each other, which could mean that these compounds are 
not endogenous. However further measurements are needed to verify these preliminary 
results. The monitoring of all the parameters necessary to calculate the compounds 
concentration in ambient air is of utmost importance, in order to compare those present 
in breath samples. 
 
It is clear that EBC could contain many potential markers. Collection of EBC is a 
completely non invasive method of breath sampling, collection devices are portable and 
can be used in a wide range of settings including intensive care units, workplaces and at 
home. It is now important to optimise their measurements and to study the clinical 
value of monitoring markers in breath in a variety of specific diseases and establish the 
reproducibility of these measurements. This is a complex task as each marker needs to 
be considered individually due to differing solubility, stability, volatility and 
amounts130. 
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Conclusions 
 
 
The validation of an analytical methods on the one hand and the development of 
sampling system on the other hand are the most significantly contributions made by this 
research work. Single molecules or sets and/or patterns of exhaled biomarkers were 
also investigated in order to establish correlations between the composition of breath 
and patients’ clinical conditions. 
 
The results show the critical aspects that currently limit the use of breath analysis for 
clinical diagnoses.  In fact the direct identification of disease markers presents various 
problems, such as the high levels of interfering substances and the inter- and intra- 
individual variability.  In addition, the metabolic pathways that give rise to their 
production are not always known, and the complexity of human physiology makes their 
determination a challenging task.  
 
Furthermore, depending on the type of breath or the sampling technique used, the 
results can vary considerably. Therefore, the standardization of methods is important 
for improved interpretation of data among subjects who are or are not exposed to VOC. 
 
For this reason, many studies must be performed and if the diagnostic potential of 
breath analysis is to be used in clinical practice, we have to learn more about origins, 
physiological bases, and exhalation kinetics of the volatile substances.  
 
The research has been aimed at specific pathologies, involving a suitable statistical 
number of subjects in order to define for each parameters, the ranges of “normality” 
and the ranges of disease pathologies. 
 
Simplification is essential, because the methods currently employed to collect, 
concentrate and assay breath samples are too complicated and expensive for general 
use. A new generation of instruments providing quick readouts could transform breath 
analysis into an inexpensive and useful screening test for many different diseases and 
thus increase its diffusion. In our opinion, dedicated infrared spectrometers or mass 
spectrometers, and sensor-based systems would be the main candidates for such a new 
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generation. Sensor systems, in particular, should be able to combine high throughput 
and ease of use with low costs.  
 
Finally the progress will require teamwork amongst device makers, experts in breath 
analysis, and clinicians.  
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